BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010;7:425-36. [DOI: 10.1038/nrgastro.2010.97] [Cited by in Crossref: 401] [Cited by in F6Publishing: 390] [Article Influence: 33.4] [Reference Citation Analysis]
Number Citing Articles
1 Dai Y, Zhao Z, Liu C. Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis. Front Pharmacol 2022;13:942841. [DOI: 10.3389/fphar.2022.942841] [Reference Citation Analysis]
2 Sun C, Zhang H, Liu X. Emerging role of CCN family proteins in fibrosis. J Cell Physiol 2021;236:4195-206. [PMID: 33222181 DOI: 10.1002/jcp.30171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Vinken M. Adverse Outcome Pathways as Tools to Assess Drug-Induced Toxicity. Methods Mol Biol 2016;1425:325-37. [PMID: 27311472 DOI: 10.1007/978-1-4939-3609-0_14] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
4 Fausther M, Lavoie EG, Dranoff JA. Contribution of Myofibroblasts of Different Origins to Liver Fibrosis. Curr Pathobiol Rep 2013;1:225-30. [PMID: 23997993 DOI: 10.1007/s40139-013-0020-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
5 Chen BX, Cao HL, Guo RH, Jin SQ, Bai B. Prostaglandin E1 for prevention and treatment of liver fibrosis progression after hepatic arterial embolization in a rabbit model. Shijie Huaren Xiaohua Zazhi 2014; 22(2): 164-170 [DOI: 10.11569/wcjd.v22.i2.164] [Reference Citation Analysis]
6 Lee DY, Yun SM, Song MY, Ji SD, Son JG, Kim EH. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats. Cells 2020;9:E568. [PMID: 32121064 DOI: 10.3390/cells9030568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Clark PJ, Patel K. Noninvasive tools to assess liver disease. Curr Opin Gastroenterol. 2011;27:210-216. [PMID: 21248634 DOI: 10.1097/MOG.0b013e328343e9a3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
8 Kong M, Hong W, Shao Y, Lv F, Fan Z, Li P, Xu Y, Guo J. Ablation of serum response factor in hepatic stellate cells attenuates liver fibrosis. J Mol Med (Berl) 2019;97:1521-33. [PMID: 31435710 DOI: 10.1007/s00109-019-01831-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
9 Yanagawa T, Sumiyoshi H, Higashi K, Nakao S, Higashiyama R, Fukumitsu H, Minakawa K, Chiba Y, Suzuki Y, Sumida K, Saito K, Kamiya A, Inagaki Y. Identification of a Novel Bone Marrow Cell-Derived Accelerator of Fibrotic Liver Regeneration Through Mobilization of Hepatic Progenitor Cells in Mice. Stem Cells 2019;37:89-101. [PMID: 30270488 DOI: 10.1002/stem.2916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
10 Piao R, Xiu M, Brigstock DR, Gao R. An immortalized rat pancreatic stellate cell line RP-2 as a new cell model for evaluating pancreatic fibrosis, inflammation and immunity. Hepatobiliary & Pancreatic Diseases International 2015;14:651-9. [DOI: 10.1016/s1499-3872(15)60415-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chen G, Xia B, Fu Q, Huang X, Wang F, Chen Z, Lv Y. Matrix Mechanics as Regulatory Factors and Therapeutic Targets in Hepatic Fibrosis. Int J Biol Sci 2019;15:2509-21. [PMID: 31754325 DOI: 10.7150/ijbs.37500] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Kong M, Wu J, Fan Z, Chen B, Wu T, Xu Y. The histone demethylase Kdm4 suppresses activation of hepatic stellate cell by inducing MiR-29 transcription. Biochem Biophys Res Commun 2019;514:16-23. [PMID: 31014673 DOI: 10.1016/j.bbrc.2019.04.105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liu H, Chen Z, Jin W, Barve A, Wan YY, Cheng K. Silencing of α-complex protein-2 reverses alcohol- and cytokine-induced fibrogenesis in hepatic stellate cells. Liver Res 2017;1:70-9. [PMID: 28966795 DOI: 10.1016/j.livres.2017.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
14 Yovchev MI, Xue Y, Shafritz DA, Locker J, Oertel M. Repopulation of the fibrotic/cirrhotic rat liver by transplanted hepatic stem/progenitor cells and mature hepatocytes. Hepatology 2014;59:284-95. [PMID: 23840008 DOI: 10.1002/hep.26615] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
15 Wong GL. Prediction of fibrosis progression in chronic viral hepatitis. Clin Mol Hepatol 2014;20:228-36. [PMID: 25320725 DOI: 10.3350/cmh.2014.20.3.228] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
16 Kumar R, Teo EK, How CH, Wong TY, Ang TL. A practical clinical approach to liver fibrosis. Singapore Med J 2018;59:628-33. [PMID: 30631885 DOI: 10.11622/smedj.2018145] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Saneyasu T, Akhtar R, Sakai T. Molecular Cues Guiding Matrix Stiffness in Liver Fibrosis. Biomed Res Int 2016;2016:2646212. [PMID: 27800489 DOI: 10.1155/2016/2646212] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
18 Lu Y, Lv F, Kong M, Chen X, Duan Y, Chen X, Sun D, Fang M, Xu Y. A cAbl-MRTF-A Feedback Loop Contributes to Hepatic Stellate Cell Activation. Front Cell Dev Biol 2019;7:243. [PMID: 31681772 DOI: 10.3389/fcell.2019.00243] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
19 Yuan Y, Han Q, Li S, Tian Z, Zhang J. Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling. Sci Rep 2017;7:3952. [PMID: 28638086 DOI: 10.1038/s41598-017-04374-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
20 Yue Z, Jiang Z, Ruan B, Duan J, Song P, Liu J, Han H, Wang L. Disruption of myofibroblastic Notch signaling attenuates liver fibrosis by modulating fibrosis progression and regression. Int J Biol Sci 2021;17:2135-46. [PMID: 34239344 DOI: 10.7150/ijbs.60056] [Reference Citation Analysis]
21 Oh Y, Park O, Swierczewska M, Hamilton JP, Park JS, Kim TH, Lim SM, Eom H, Jo DG, Lee CE, Kechrid R, Mastorakos P, Zhang C, Hahn SK, Jeon OC, Byun Y, Kim K, Hanes J, Lee KC, Pomper MG, Gao B, Lee S. Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells. Hepatology 2016;64:209-23. [PMID: 26710118 DOI: 10.1002/hep.28432] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
22 Qiao J, Fan Q, Xing L, Cui P, He Y, Zhu J, Wang L, Pang T, Oh Y, Zhang C, Jiang H. Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis. Journal of Controlled Release 2018;283:113-25. [DOI: 10.1016/j.jconrel.2018.05.032] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
23 Serai SD, Dillman JR, Trout AT. Spin-echo Echo-planar Imaging MR Elastography versus Gradient-echo MR Elastography for Assessment of Liver Stiffness in Children and Young Adults Suspected of Having Liver Disease. Radiology 2017;282:761-70. [DOI: 10.1148/radiol.2016160589] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 8.8] [Reference Citation Analysis]
24 Iizuka M, Ogawa T, Enomoto M, Motoyama H, Yoshizato K, Ikeda K, Kawada N. Induction of microRNA-214-5p in human and rodent liver fibrosis. Fibrogenesis Tissue Repair. 2012;5:12. [PMID: 22849305 DOI: 10.1186/1755-1536-5-12] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
25 Ma Y, Yuan H, Jin R, Bao X, Wang H, Su X, Mu MGSL, Liang J, Zhang J, Wu X. Flavonoid-rich Scabiosa comosa inflorescence extract attenuates CCl4-induced hepatic fibrosis by modulating TGF-β-induced Smad3 phosphorylation. Biomedicine & Pharmacotherapy 2018;106:426-33. [DOI: 10.1016/j.biopha.2018.06.118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
26 Wen Z, Ji X, Tang J, Lin G, Xiao L, Liang C, Wang M, Su F, Ferrandon D, Li Z. Positive Feedback Regulation between Transglutaminase 2 and Toll-Like Receptor 4 Signaling in Hepatic Stellate Cells Correlates with Liver Fibrosis Post Schistosoma japonicum Infection. Front Immunol 2017;8:1808. [PMID: 29321784 DOI: 10.3389/fimmu.2017.01808] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
27 Liu X, Wu Y, Yang Y, Li W, Huang C, Meng X, Li J. Role of NLRC5 in progression and reversal of hepatic fibrosis. Toxicology and Applied Pharmacology 2016;294:43-53. [DOI: 10.1016/j.taap.2016.01.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
28 Wang H, Lafdil F, Wang L, Yin S, Feng D, Gao B. Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 production. Cell Biosci. 2011;1:14. [PMID: 21711826 DOI: 10.1186/2045-3701-1-14] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
29 Sakai K, Jawaid S, Sasaki T, Bou-Gharios G, Sakai T. Transforming growth factor-β-independent role of connective tissue growth factor in the development of liver fibrosis. Am J Pathol 2014;184:2611-7. [PMID: 25108224 DOI: 10.1016/j.ajpath.2014.06.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
30 Bai L, Kong M, Zhang XH, Ding M, Zheng SJ, Chen Y, Duan ZP. Liver fibrosis protects mice against lethal injury induced by D-GalN/LPS. Shijie Huaren Xiaohua Zazhi 2014; 22(14): 1998-2002 [DOI: 10.11569/wcjd.v22.i14.1998] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Karthikeyan S, Potter JJ, Geschwind JF, Sur S, Hamilton JP, Vogelstein B, Kinzler KW, Mezey E, Ganapathy-Kanniappan S. Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model. Biochem Biophys Res Commun 2016;469:463-9. [PMID: 26525850 DOI: 10.1016/j.bbrc.2015.10.101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
32 Chang ML, Liang KH, Ku CL, Lo CC, Cheng YT, Hsu CM, Yeh CT, Chiu CT. Resistin reinforces interferon λ-3 to eliminate hepatitis C virus with fine-tuning from RETN single-nucleotide polymorphisms. Sci Rep 2016;6:30799. [PMID: 27477870 DOI: 10.1038/srep30799] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
33 Chen P, Li J, Huo Y, Lu J, Wan L, Yang Q, Huang J, Gan R, Guo C. Adenovirus-mediated expression of orphan nuclear receptor NR4A2 targeting hepatic stellate cell attenuates liver fibrosis in rats. Sci Rep 2016;6:33593. [PMID: 27646469 DOI: 10.1038/srep33593] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
34 Park SA, Kim MJ, Park SY, Kim JS, Lee SJ, Woo HA, Kim DK, Nam JS, Sheen YY. EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling. Cell Mol Life Sci 2015;72:2023-39. [PMID: 25487606 DOI: 10.1007/s00018-014-1798-6] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 7.5] [Reference Citation Analysis]
35 Chen L, Zhang C, Chen L, Wang X, Xiang B, Wu X, Guo Y, Mou X, Yuan L, Chen B, Wang J, Xiang C. Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators. Stem Cells Transl Med. 2017;6:272-284. [PMID: 28170193 DOI: 10.5966/sctm.2015-0265] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 7.8] [Reference Citation Analysis]
36 Yu X, Guo R, Ming D, Su M, Lin C, Deng Y, Lin Z, Su Z. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis. J Gastroenterol Hepatol. 2014;29:1065-1072. [PMID: 24236690 DOI: 10.1111/jgh.12459] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
37 Shaker ME, Eisa NH, Elgaml A, El-Mesery A, El-Shafey M, El-Dosoky M, El-Mowafy M, El-Mesery M. Ingestion of mannose ameliorates thioacetamide-induced intrahepatic oxidative stress, inflammation and fibrosis in rats. Life Sci 2021;286:120040. [PMID: 34637794 DOI: 10.1016/j.lfs.2021.120040] [Reference Citation Analysis]
38 Cardoso AC, Figueiredo-Mendes C, Villela-Nogueira CA, Marcellin P. Staging Fibrosis in Chronic Viral Hepatitis. Viruses 2022;14:660. [PMID: 35458391 DOI: 10.3390/v14040660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Borkham-Kamphorst E, Steffen BT, Van de Leur E, Haas U, Tihaa L, Friedman SL, Weiskirchen R. CCN1/CYR61 overexpression in hepatic stellate cells induces ER stress-related apoptosis. Cell Signal 2016;28:34-42. [PMID: 26515130 DOI: 10.1016/j.cellsig.2015.10.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
40 Verbeke L, Mannaerts I, Schierwagen R, Govaere O, Klein S, Vander Elst I, Windmolders P, Farre R, Wenes M, Mazzone M, Nevens F, van Grunsven LA, Trebicka J, Laleman W. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis. Sci Rep. 2016;6:33453. [PMID: 27634375 DOI: 10.1038/srep33453] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 17.5] [Reference Citation Analysis]
41 Yang QG, Liu SN. P38 MAPK signaling pathway and hepatic fibrosis. Shijie Huaren Xiaohua Zazhi 2012; 20(24): 2231-2236 [DOI: 10.11569/wcjd.v20.i24.2231] [Reference Citation Analysis]
42 Lecarpentier Y, Schussler O, Claes V, Vallée A. The Myofibroblast: TGFβ-1, A Conductor which Plays a Key Role in Fibrosis by Regulating the Balance between PPARγ and the Canonical WNT Pathway. Nuclear Receptor Research 2017;4. [DOI: 10.11131/2017/101299] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 2.4] [Reference Citation Analysis]
43 Tao Y, Qiu T, Yao X, Jiang L, Wang N, Jiang J, Jia X, Wei S, Zhang J, Zhu Y, Tian W, Yang G, Liu X, Liu S, Ding Y, Sun X. IRE1α/NOX4 signaling pathway mediates ROS-dependent activation of hepatic stellate cells in NaAsO2 -induced liver fibrosis. J Cell Physiol 2021;236:1469-80. [PMID: 32776539 DOI: 10.1002/jcp.29952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
44 Borgia M, Dal Bo M, Toffoli G. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4387. [PMID: 34503196 DOI: 10.3390/cancers13174387] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Poelstra K, Prakash J, Beljaars L. Drug targeting to the diseased liver. Journal of Controlled Release 2012;161:188-97. [DOI: 10.1016/j.jconrel.2012.02.011] [Cited by in Crossref: 101] [Cited by in F6Publishing: 100] [Article Influence: 10.1] [Reference Citation Analysis]
46 Yu JH, Lee JI. Current role of transient elastography in the management of chronic hepatitis B patients. Ultrasonography. 2017;36:86-94. [PMID: 27956732 DOI: 10.14366/usg.16023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
47 Borkham-Kamphorst E, Schaffrath C, Van de Leur E, Haas U, Tihaa L, Meurer SK, Nevzorova YA, Liedtke C, Weiskirchen R. The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling. Biochim Biophys Acta 2014;1843:902-14. [PMID: 24487063 DOI: 10.1016/j.bbamcr.2014.01.023] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 8.1] [Reference Citation Analysis]
48 Wang Y, Fan X, Lei N, He X, Wang X, Luo X, Zhang D, Pan W. A MicroRNA Derived From Schistosoma japonicum Promotes Schistosomiasis Hepatic Fibrosis by Targeting Host Secreted Frizzled-Related Protein 1. Front Cell Infect Microbiol 2020;10:101. [PMID: 32232014 DOI: 10.3389/fcimb.2020.00101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Patel K, Tillmann HL, Matta B, Sheridan MJ, Gardner SD, Shackel NA, McHutchison JG, Goodman ZD. Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers. Aliment Pharmacol Ther 2016;43:356-63. [PMID: 26560052 DOI: 10.1111/apt.13471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Wang Y, Hou JL. Current strategies for quantitating fibrosis in liver biopsy. Chin Med J (Engl) 2015;128:252-8. [PMID: 25591571 DOI: 10.4103/0366-6999.149223] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
51 Lukashyk SP, Tsyrkunov VM, Isaykina YI, Romanova ON, Shymanskiy AT, Aleynikova OV, Kravchuk RI. Mesenchymal bone marrow-derived stem cells transplantation in patients with HCV related liver cirrhosis. J Clin Transl Hepatol. 2014;2:217-221. [PMID: 26356872 DOI: 10.14218/JCTH.2014.00027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
52 Zhang F, Jin H, Wu L, Shao J, Zhu X, Chen A, Zheng S. Diallyl Trisulfide Suppresses Oxidative Stress-Induced Activation of Hepatic Stellate Cells through Production of Hydrogen Sulfide. Oxid Med Cell Longev. 2017;2017:1406726. [PMID: 28303169 DOI: 10.1155/2017/1406726] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
53 Kotsiou OS, Gourgoulianis KI, Zarogiannis SG. IL-33/ST2 Axis in Organ Fibrosis. Front Immunol 2018;9:2432. [PMID: 30405626 DOI: 10.3389/fimmu.2018.02432] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 11.8] [Reference Citation Analysis]
54 Yu SJ. Regression of liver cirrhosis: orthodoxy or paradigm shift? Clin Mol Hepatol 2015;21:22-3. [PMID: 25834798 DOI: 10.3350/cmh.2015.21.1.22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Chen L, Guo YZ, Li AD, Ma JJ, Hao HY, Zhang D, Wang Y, Ji CG, Qi W, Wang J, Jiang HQ. Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells. Dig Dis Sci 2016;61:1961-71. [PMID: 26879903 DOI: 10.1007/s10620-016-4075-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
56 Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol. 2012;56:1171-1180. [PMID: 22245903 DOI: 10.1016/j.jhep.2011.09.024] [Cited by in Crossref: 253] [Cited by in F6Publishing: 243] [Article Influence: 25.3] [Reference Citation Analysis]
57 Tu X, Zhang H, Zhang J, Zhao S, Zheng X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway. J Pathol. 2014;234:46-59. [PMID: 24817606 DOI: 10.1002/path.4373] [Cited by in Crossref: 88] [Cited by in F6Publishing: 94] [Article Influence: 11.0] [Reference Citation Analysis]
58 Du Y, Ma J, Fan Y, Wang X, Zheng S, Feng J, Li J, Fan Z, Li G, Ye Q. Naringenin: A Promising Therapeutic Agent against Organ Fibrosis. Oxid Med Cell Longev 2021;2021:1210675. [PMID: 34804359 DOI: 10.1155/2021/1210675] [Reference Citation Analysis]
59 Yang J, Liu Q, Cao S, Xu T, Li X, Zhou D, Pan L, Li C, Huang C, Meng X, Zhang L, Wang X. MicroRNA-145 Increases the Apoptosis of Activated Hepatic Stellate Cells Induced by TRAIL through NF-κB Signaling Pathway. Front Pharmacol 2017;8:980. [PMID: 29375381 DOI: 10.3389/fphar.2017.00980] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
60 Yoshida K, Murata M, Yamaguchi T, Matsuzaki K. TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review). Int J Oncol 2014;45:1363-71. [PMID: 25050845 DOI: 10.3892/ijo.2014.2552] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 9.5] [Reference Citation Analysis]
61 Nelson PE, Surzycki SJ. Characterization of the oxygenase activity in a mutant of Chlamydomonas reinhardi exhibiting altered ribulosebisphosphate carboxylase. Eur J Biochem 1976;61:475-80. [PMID: 2467 DOI: 10.1111/j.1432-1033.1976.tb10041.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
62 Ahmad A, Ahmad R. Resveratrol mitigate structural changes and hepatic stellate cell activation in N'-nitrosodimethylamine-induced liver fibrosis via restraining oxidative damage. Chem Biol Interact 2014;221:1-12. [PMID: 25064540 DOI: 10.1016/j.cbi.2014.07.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
63 Bexfield N. Canine Idiopathic Chronic Hepatitis. Vet Clin North Am Small Anim Pract 2017;47:645-63. [PMID: 28063746 DOI: 10.1016/j.cvsm.2016.11.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
64 Hu D, Hu Y, Xu W, Yu H, Yang N, Ni S, Fu R. miR‑203 inhibits the expression of collagen‑related genes and the proliferation of hepatic stellate cells through a SMAD3‑dependent mechanism. Mol Med Rep 2017;16:1248-54. [PMID: 28586069 DOI: 10.3892/mmr.2017.6702] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
65 Pomper MG, Lee S. Molecularly Targeted MR Imaging Agent in Liver Fibrosis: High Sensitivity and Low Gadolinium Mean High Translational Potential. Radiology 2018;287:590-1. [DOI: 10.1148/radiol.2018180084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Wu D, Bao C, Li L, Fu M, Wang D, Xie J, Gong X. Chlorogenic acid protects against cholestatic liver injury in rats. Journal of Pharmacological Sciences 2015;129:177-82. [DOI: 10.1016/j.jphs.2015.10.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
67 Serai SD, Towbin AJ, Podberesky DJ. Pediatric liver MR elastography. Dig Dis Sci. 2012;57:2713-2719. [PMID: 22569825 DOI: 10.1007/s10620-012-2196-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 4.7] [Reference Citation Analysis]
68 Yu G, Mu H, Zhou H, Fang F, Cui Y, Wu Q, Xiong Q, Li H. MicroRNA-361 suppresses the biological processes of hepatic stellate cells in HBV-relative hepatic fibrosis by NF-kappaB p65. Cells Dev 2021;167:203711. [PMID: 34216805 DOI: 10.1016/j.cdev.2021.203711] [Reference Citation Analysis]
69 Qian H, Deng X, Huang ZW, Wei J, Ding CH, Feng RX, Zeng X, Chen YX, Ding J, Qiu L, Hu ZL, Zhang X, Wang HY, Zhang JP, Xie WF. An HNF1α-regulated feedback circuit modulates hepatic fibrogenesis via the crosstalk between hepatocytes and hepatic stellate cells. Cell Res 2015;25:930-45. [PMID: 26169608 DOI: 10.1038/cr.2015.84] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
70 Yan Y, Zeng J, Xing L, Li C. Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation. Biomedicines 2021;9:1014. [PMID: 34440218 DOI: 10.3390/biomedicines9081014] [Reference Citation Analysis]
71 Riaz F, Chen Q, Lu K, Osoro EK, Wu L, Feng L, Zhao R, Yang L, Zhou Y, He Y, Zhu L, Du X, Sadiq M, Yang X, Li D. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway. J Cell Mol Med 2021;25:4073-87. [PMID: 33689215 DOI: 10.1111/jcmm.16376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
72 Li J, Wang Y, Ma M, Jiang S, Zhang X, Zhang Y, Yang X, Xu C, Tian G, Li Q, Wang Y, Zhu L, Nie H, Feng M, Xia Q, Gu J, Xu Q, Zhang Z. Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling. EBioMedicine 2019;40:43-55. [PMID: 30639416 DOI: 10.1016/j.ebiom.2019.01.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
73 Liu X, Zhao X. Scoparone attenuates hepatic stellate cell activation through inhibiting TGF-β/Smad signaling pathway. Biomedicine & Pharmacotherapy 2017;93:57-61. [DOI: 10.1016/j.biopha.2017.06.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
74 Zong Z, Liu J, Wang N, Yang C, Wang Q, Zhang W, Chen Y, Liu X, Deng H. Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE2 degradation. Free Radic Biol Med 2021;162:571-81. [PMID: 33220424 DOI: 10.1016/j.freeradbiomed.2020.11.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
75 Tian F, Liu Y, Gao J, Yang N, Shang X, Lv J, Ba D, Zhou X, Zhang C, Ma X. Study on the association between TGF-β1 and liver fibrosis in patients with hepatic cystic echinococcosis. Exp Ther Med 2020;19:1275-80. [PMID: 32010299 DOI: 10.3892/etm.2019.8355] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Michailidou Z, Turban S, Miller E, Zou X, Schrader J, Ratcliffe PJ, Hadoke PW, Walker BR, Iredale JP, Morton NM, Seckl JR. Increased angiogenesis protects against adipose hypoxia and fibrosis in metabolic disease-resistant 11β-hydroxysteroid dehydrogenase type 1 (HSD1)-deficient mice. J Biol Chem 2012;287:4188-97. [PMID: 22158867 DOI: 10.1074/jbc.M111.259325] [Cited by in Crossref: 62] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
77 Saraswathy A, Nazeer SS, Nimi N, Santhakumar H, Suma PR, Jibin K, Victor M, Fernandez FB, Arumugam S, Shenoy SJ, Varma PRH, Jayasree RS. Asialoglycoprotein receptor targeted optical and magnetic resonance imaging and therapy of liver fibrosis using pullulan stabilized multi-functional iron oxide nanoprobe. Sci Rep 2021;11:18324. [PMID: 34526590 DOI: 10.1038/s41598-021-97808-0] [Reference Citation Analysis]
78 Park JH, Kim OH, Kim KH, Hong HE, Seo H, Choi HJ, Ahn J, Lee TY, Kim SJ. Isolation of Secretome with Enhanced Antifibrotic Properties from miR-214-Transfected Adipose-Derived Stem Cells. J Korean Med Sci 2019;34:e273. [PMID: 31760709 DOI: 10.3346/jkms.2019.34.e273] [Reference Citation Analysis]
79 Huang YH, Kuo HC, Yang YL, Wang FS. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation. Int J Med Sci 2019;16:212-20. [PMID: 30745801 DOI: 10.7150/ijms.29930] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
80 Jiang Y, Wu C, Boye A, Wu J, Wang J, Yang X, Yang Y. MAPK inhibitors modulate Smad2/3/4 complex cyto-nuclear translocation in myofibroblasts via Imp7/8 mediation. Mol Cell Biochem 2015;406:255-62. [PMID: 25968067 DOI: 10.1007/s11010-015-2443-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
81 Zhang M, Wang Y, Zhu G, Sun C, Wang J. Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride-induced liver fibrosis in mice. Naunyn Schmiedebergs Arch Pharmacol 2021;394:189-204. [PMID: 32474674 DOI: 10.1007/s00210-020-01891-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Manne V, Saab S. Coffee as modulator of liver injury: Fact and fiction. Clin Liver Dis (Hoboken) 2015;6:139-41. [PMID: 31041011 DOI: 10.1002/cld.517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
83 Kim KS, Yang HJ, Lee JY, Na YC, Kwon SY, Kim YC, Lee JH, Jang HJ. Effects of β-sitosterol derived from Artemisia capillaris on the activated human hepatic stellate cells and dimethylnitrosamine-induced mouse liver fibrosis. BMC Complement Altern Med 2014;14:363. [PMID: 25262005 DOI: 10.1186/1472-6882-14-363] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
84 Maharjan S, Bonilla D, Sindurakar P, Li H, Li W, Duarte S, Zarrinpar A, Zhang YS. 3D human nonalcoholic hepatic steatosis and fibrosis models. Bio-des Manuf 2021;4:157-70. [DOI: 10.1007/s42242-020-00121-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
85 Khatun M, Ray RB. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis. Cells 2019;8:E1249. [PMID: 31615075 DOI: 10.3390/cells8101249] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 14.3] [Reference Citation Analysis]
86 Zhang XW, Zhou JC, Peng D, Hua F, Li K, Yu JJ, Lv XX, Cui B, Liu SS, Yu JM, Wang F, Jin CC, Yang ZN, Zhao CX, Hou XY, Huang B, Hu ZW. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation. Autophagy 2020;16:782-96. [PMID: 31286822 DOI: 10.1080/15548627.2019.1635383] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
87 Liu H, Cen D, Yu Y, Wang Y, Liang X, Lin H, Cai X. Does fibrosis have an impact on survival of patients with hepatocellular carcinoma: evidence from the SEER database? BMC Cancer 2018;18:1125. [PMID: 30445928 DOI: 10.1186/s12885-018-4996-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
88 Wang Y, Zhang X, Yang Y, Yang X, Ye B. Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo. Mar Drugs 2015;13:5201-18. [PMID: 26295240 DOI: 10.3390/md13085201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
89 Hoshida Y. Molecular Epidemiology of Hepatocellular Carcinoma. Clin Liver Dis (Hoboken) 2012;1:177-9. [PMID: 26213618 DOI: 10.1002/cld.117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
90 Halder S, Ogino M, Seto Y, Sato H, Onoue S. Improved biopharmaceutical properties of carvedilol employing α-tocopheryl polyethylene glycol 1000 succinate-based self-emulsifying drug delivery system. Drug Dev Ind Pharm 2018;44:1838-44. [PMID: 30059249 DOI: 10.1080/03639045.2018.1503294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
91 Beljaars L, Schippers M, Reker-Smit C, Martinez FO, Helming L, Poelstra K, Melgert BN. Hepatic Localization of Macrophage Phenotypes during Fibrogenesis and Resolution of Fibrosis in Mice and Humans. Front Immunol 2014;5:430. [PMID: 25250030 DOI: 10.3389/fimmu.2014.00430] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]
92 Ma L, Yang X, Wei R, Ye T, Zhou JK, Wen M, Men R, Li P, Dong B, Liu L, Fu X, Xu H, Aqeilan RI, Wei YQ, Yang L, Peng Y. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression. Cell Death Dis. 2018;9:718. [PMID: 29915227 DOI: 10.1038/s41419-018-0752-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
93 Sun X, Tan Y, Lyu J, Liu HL, Zhao ZM, Liu CH. Active Components Formulation Developed from Fuzheng Huayu Recipe () for Anti-Liver Fibrosis. Chin J Integr Med 2021. [PMID: 34581939 DOI: 10.1007/s11655-021-3293-x] [Reference Citation Analysis]
94 Fan Y, Du Z, Steib CJ, Ding Q, Lu P, Tian D, Liu M. Effect of SEPT6 on the biological behavior of hepatic stellate cells and liver fibrosis in rats and its mechanism. Lab Invest 2019;99:17-36. [PMID: 30315255 DOI: 10.1038/s41374-018-0133-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
95 Zhang JX, Li P, Chen Z, Lin H, Cai Z, Liao W, Pan Z. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis. BMC Cancer 2020;20:556. [PMID: 32539768 DOI: 10.1186/s12885-020-07051-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Serai SD, Yin M, Wang H, Ehman RL, Podberesky DJ. Cross-vendor validation of liver magnetic resonance elastography. Abdom Imaging. 2015;40:789-794. [PMID: 25476489 DOI: 10.1007/s00261-014-0282-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
97 Li H, Zheng HW, Chen H, Xing ZZ, You H, Cong M, Jia JD. Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-β1 over pro-inflammatory cytokines. Dig Liver Dis. 2012;44:328-333. [PMID: 22177317 DOI: 10.1016/j.dld.2011.11.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
98 Challa AA, Vukmirovic M, Blackmon J, Stefanovic B. Withaferin-A reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivo. PLoS One 2012;7:e42989. [PMID: 22900077 DOI: 10.1371/journal.pone.0042989] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
99 Swiderska-Syn M, Xie G, Michelotti GA, Jewell ML, Premont RT, Syn WK, Diehl AM. Hedgehog regulates yes-associated protein 1 in regenerating mouse liver. Hepatology 2016;64:232-44. [PMID: 26970079 DOI: 10.1002/hep.28542] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 10.7] [Reference Citation Analysis]
100 Farrar CT, DePeralta DK, Day H, Rietz TA, Wei L, Lauwers GY, Keil B, Subramaniam A, Sinskey AJ, Tanabe KK, Fuchs BC, Caravan P. 3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model. J Hepatol 2015;63:689-96. [PMID: 26022693 DOI: 10.1016/j.jhep.2015.04.029] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
101 Fuchs BC, Wang H, Yang Y, Wei L, Polasek M, Schühle DT, Lauwers GY, Parkar A, Sinskey AJ, Tanabe KK, Caravan P. Molecular MRI of collagen to diagnose and stage liver fibrosis. J Hepatol 2013;59:992-8. [PMID: 23838178 DOI: 10.1016/j.jhep.2013.06.026] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 10.4] [Reference Citation Analysis]
102 Berenguer M, Schuppan D. Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment. J Hepatol. 2013;58:1028-1041. [PMID: 23262248 DOI: 10.1016/j.jhep.2012.12.014] [Cited by in Crossref: 104] [Cited by in F6Publishing: 88] [Article Influence: 10.4] [Reference Citation Analysis]
103 Zhang Y, Hagedorn CH, Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta 2011;1812:893-908. [PMID: 20970497 DOI: 10.1016/j.bbadis.2010.10.006] [Cited by in Crossref: 147] [Cited by in F6Publishing: 146] [Article Influence: 12.3] [Reference Citation Analysis]
104 Tao Y, Qiu T, Yao X, Jiang L, Wang N, Jia X, Wei S, Wang Z, Pei P, Zhang J, Zhu Y, Yang G, Liu X, Liu S, Sun X. Autophagic-CTSB-inflammasome axis modulates hepatic stellate cells activation in arsenic-induced liver fibrosis. Chemosphere 2020;242:124959. [DOI: 10.1016/j.chemosphere.2019.124959] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
105 Enomoto M, Morikawa H, Tamori A, Kawada N. Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B. World J Gastroenterol 2014; 20(34): 12031-12038 [PMID: 25232240 DOI: 10.3748/wjg.v20.i34.12031] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
106 Kuo LM, Kuo CY, Lin CY, Hung MF, Shen JJ, Hwang TL. Intracellular glutathione depletion by oridonin leads to apoptosis in hepatic stellate cells. Molecules 2014;19:3327-44. [PMID: 24647034 DOI: 10.3390/molecules19033327] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 8.5] [Reference Citation Analysis]
107 Carthy JM. TGFβ signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders. J Cell Physiol 2018;233:98-106. [PMID: 28247933 DOI: 10.1002/jcp.25879] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 11.6] [Reference Citation Analysis]
108 Katsumata LW, Miyajima A, Itoh T. Portal fibroblasts marked by the surface antigen Thy1 contribute to fibrosis in mouse models of cholestatic liver injury. Hepatol Commun 2017;1:198-214. [PMID: 29404454 DOI: 10.1002/hep4.1023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
109 Zhu J, Sun Z, Cheng K, Chen R, Ye M, Xu B, Sun D, Wang L, Liu J, Wang F, Zou H. Comprehensive Mapping of Protein N-Glycosylation in Human Liver by Combining Hydrophilic Interaction Chromatography and Hydrazide Chemistry. J Proteome Res 2014;13:1713-21. [DOI: 10.1021/pr401200h] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 7.0] [Reference Citation Analysis]
110 Sun HQ, Zhang JY, Zhang H, Zou ZS, Wang FS, Jia JH. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat. 2012;19:396-403. [PMID: 22571901 DOI: 10.1111/j.1365-2893.2011.01561.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 7.7] [Reference Citation Analysis]
111 Zhang D, Dai J, Zhang M, Xie Y, Cao Y, He G, Xu W, Wang L, Qiao Z, Qiao Z. Paternal nicotine exposure promotes hepatic fibrosis in offspring. Toxicol Lett 2021;343:44-55. [PMID: 33640489 DOI: 10.1016/j.toxlet.2021.02.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Li C, Yang C, Li X, Zhao X, Zou Y, Fan L, Zhou L, Liu J, Niu Y. Hydroxysafflor yellow A induces apoptosis in activated hepatic stellate cells through ERK1/2 pathway in vitro. European Journal of Pharmaceutical Sciences 2012;46:397-404. [DOI: 10.1016/j.ejps.2012.03.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
113 Ye J, Wu S, Pan S, Huang J, Ge L. Risk scoring based on expression of long non‑coding RNAs can effectively predict survival in hepatocellular carcinoma patients with or without fibrosis. Oncol Rep 2020;43:1451-66. [PMID: 32323856 DOI: 10.3892/or.2020.7528] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
114 Kikuchi A, Monga SP. PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer. Gene Expr 2015;16:109-27. [PMID: 25700367 DOI: 10.3727/105221615X14181438356210] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
115 Horvat T, Landesmann B, Lostia A, Vinken M, Munn S, Whelan M. Adverse outcome pathway development from protein alkylation to liver fibrosis. Arch Toxicol 2017;91:1523-43. [PMID: 27542122 DOI: 10.1007/s00204-016-1814-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
116 Zhang Z, Zha Y, Hu W, Huang Z, Gao Z, Zang Y, Chen J, Dong L, Zhang J. The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development. J Biol Chem. 2013;288:37082-37093. [PMID: 24196965 DOI: 10.1074/jbc.M113.517953] [Cited by in Crossref: 76] [Cited by in F6Publishing: 47] [Article Influence: 8.4] [Reference Citation Analysis]
117 Bodewes FA, van der Doef HP, Houwen RH, Verkade HJ. Increase of Serum γ-Glutamyltransferase Associated With Development of Cirrhotic Cystic Fibrosis Liver Disease. Journal of Pediatric Gastroenterology & Nutrition 2015;61:113-8. [DOI: 10.1097/mpg.0000000000000758] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
118 Zhang Z, Zhang F, Lu Y, Zheng S. Update on implications and mechanisms of angiogenesis in liver fibrosis. Hepatol Res 2015;45:162-78. [PMID: 25196587 DOI: 10.1111/hepr.12415] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
119 Liu Y, Lv W. Research Progress in Astragalus Membranaceus and Its Active Components on Immune Responses in Liver Fibrosis. Chin J Integr Med 2020;26:794-800. [DOI: 10.1007/s11655-019-3039-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
120 Wen J. Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease. Clin Transl Sci 2011;4:460-5. [PMID: 22212229 DOI: 10.1111/j.1752-8062.2011.00306.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
121 Perugorria MJ, Olaizola P, Labiano I, Esparza-Baquer A, Marzioni M, Marin JJG, Bujanda L, Banales JM. Wnt-β-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol 2019;16:121-36. [PMID: 30451972 DOI: 10.1038/s41575-018-0075-9] [Cited by in Crossref: 171] [Cited by in F6Publishing: 144] [Article Influence: 57.0] [Reference Citation Analysis]
122 Kiss K, Regős E, Rada K, Firneisz G, Baghy K, Kovalszky I. Chronic Hyperglycaemia Induced Alterations of Hepatic Stellate Cells Differ from the Effect of TGFB1, and Point toward Metabolic Stress. Pathol Oncol Res 2020;26:291-9. [PMID: 30109568 DOI: 10.1007/s12253-018-0458-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
123 Wang H, Wang Z, Wang Y, Li X, Yang W, Wei S, Shi C, Qiu J, Ni M, Rao J, Cheng F. miRNA-130b-5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression. J Cell Mol Med 2021;25:7381-94. [PMID: 34272822 DOI: 10.1111/jcmm.16766] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Younis NS, Ghanim AMH, Elmorsy MA, Metwaly HA. Taurine ameliorates thioacetamide induced liver fibrosis in rats via modulation of toll like receptor 4/nuclear factor kappa B signaling pathway. Sci Rep 2021;11:12296. [PMID: 34112866 DOI: 10.1038/s41598-021-91666-6] [Reference Citation Analysis]
125 Yan HJ, Kwon SY, Kim K, Jeong H, Kim Y, Chung WS, Lee J, Jang H. Anti-fibrotic effects of Kyungheechunggan-tang on activated hepatic stellate cells and rat liver. Mol Cell Toxicol 2014;10:411-21. [DOI: 10.1007/s13273-014-0046-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
126 Bochaton-Piallat ML, Gabbiani G, Hinz B. The myofibroblast in wound healing and fibrosis: answered and unanswered questions. F1000Res 2016;5:F1000 Faculty Rev-752. [PMID: 27158462 DOI: 10.12688/f1000research.8190.1] [Cited by in Crossref: 131] [Cited by in F6Publishing: 120] [Article Influence: 21.8] [Reference Citation Analysis]
127 Huang S, Chang SJ, Yang M, Chen JJ, Chang WH. Nanoscale hepatoprotective herbal decoction attenuates hepatic stellate cell activity and chloroform-induced liver damage in mice. Int J Nanomedicine 2011;6:1365-71. [PMID: 21760731 DOI: 10.2147/IJN.S19503] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
128 Mahmoud MF, Swefy SE, Hasan RA, Ibrahim A. Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats. Eur J Pharmacol 2014;742:118-24. [PMID: 25179573 DOI: 10.1016/j.ejphar.2014.08.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
129 Osuna-martínez U, Reyes-esparza JA, Petricevich VL, Hernández-pando R, Rodríguez-fragoso L. Protective effect of Thymic Humoral Factor on porcine serum-induced hepatic fibrosis and liver damage in Wistar rats. Annals of Hepatology 2011;10:540-51. [DOI: 10.1016/s1665-2681(19)31523-6] [Cited by in Crossref: 9] [Article Influence: 0.8] [Reference Citation Analysis]
130 Jiang Y, Wang C, Li YY, Wang XC, An JD, Wang YJ, Wang XJ. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference. J Ethnopharmacol 2014;158 Pt A:230-8. [PMID: 25456431 DOI: 10.1016/j.jep.2014.10.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
131 Shi H, Dong L, Dang X, Liu Y, Jiang J, Wang Y, Lu X, Guo X. Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells. Inflamm Res. 2013;62:581-587. [PMID: 23483217 DOI: 10.1007/s00011-013-0610-7] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
132 Tiao MM, Wang FS, Huang LT, Chuang JH, Kuo HC, Yang YL, Huang YH. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway. Apoptosis. 2014;19:30-41. [PMID: 24052410 DOI: 10.1007/s10495-013-0909-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
133 Liu Q, Lv C, Huang Q, Zhao L, Sun X, Ning D, Liu J, Jiang Y, Jin S. ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway. Cell Death Discov 2022;8:51. [PMID: 35136027 DOI: 10.1038/s41420-022-00846-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Zhang C, Wang L, Ali T, Li L, Bi X, Wang J, Lü G, Shao Y, Vuitton DA, Wen H, Lin R. Hydatid cyst fluid promotes peri-cystic fibrosis in cystic echinococcosis by suppressing miR-19 expression. Parasit Vectors 2016;9:278. [PMID: 27177776 DOI: 10.1186/s13071-016-1562-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
135 Manojlovic Z, Blackmon J, Stefanovic B. Tacrolimus (FK506) prevents early stages of ethanol induced hepatic fibrosis by targeting LARP6 dependent mechanism of collagen synthesis. PLoS One 2013;8:e65897. [PMID: 23755290 DOI: 10.1371/journal.pone.0065897] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
136 Liu C, Billadeau DD, Abdelhakim H, Leof E, Kaibuchi K, Bernabeu C, Bloom GS, Yang L, Boardman L, Shah VH, Kang N. IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver. J Clin Invest 2013;123:1138-56. [PMID: 23454766 DOI: 10.1172/JCI63836] [Cited by in Crossref: 60] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
137 Lambrecht J, Verhulst S, Mannaerts I, Reynaert H, van Grunsven LA. Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard? Biochim Biophys Acta Mol Basis Dis. 2018;1864:1024-1036. [PMID: 29329986 DOI: 10.1016/j.bbadis.2018.01.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
138 Reichenbach V, Ros J, Fernández-Varo G, Casals G, Melgar-Lesmes P, Campos T, Makriyannis A, Morales-Ruiz M, Jiménez W. Prevention of fibrosis progression in CCl4-treated rats: role of the hepatic endocannabinoid and apelin systems. J Pharmacol Exp Ther 2012;340:629-37. [PMID: 22160265 DOI: 10.1124/jpet.111.188078] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
139 Hutchison N, Fligny C, Duffield JS. Resident mesenchymal cells and fibrosis. Biochim Biophys Acta 2013;1832:962-71. [PMID: 23220259 DOI: 10.1016/j.bbadis.2012.11.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
140 Neshat SY, Quiroz VM, Wang Y, Tamayo S, Doloff JC. Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions. Int J Mol Sci 2021;22:6777. [PMID: 34202537 DOI: 10.3390/ijms22136777] [Reference Citation Analysis]
141 Ullah A, Wang K, Wu P, Oupicky D, Sun M. CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation. Int J Nanomedicine 2019;14:2927-44. [PMID: 31118614 DOI: 10.2147/IJN.S171280] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
142 Perea L, Coll M, Sancho-bru P. Assessment of Liver Fibrotic Insults In Vitro. In: Vinken M, Rogiers V, editors. Protocols in In Vitro Hepatocyte Research. New York: Springer; 2015. pp. 391-401. [DOI: 10.1007/978-1-4939-2074-7_30] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
143 Ahmed H, Umar MI, Imran S, Javaid F, Syed SK, Riaz R, Hassan W. TGF-β1 signaling can worsen NAFLD with liver fibrosis backdrop. Exp Mol Pathol 2021;124:104733. [PMID: 34914973 DOI: 10.1016/j.yexmp.2021.104733] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Hoshida Y, Fuchs BC, Bardeesy N, Baumert TF, Chung RT. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. J Hepatol. 2014;61:S79-S90. [PMID: 25443348 DOI: 10.1016/j.jhep.2014.07.010] [Cited by in Crossref: 124] [Cited by in F6Publishing: 110] [Article Influence: 15.5] [Reference Citation Analysis]
145 Wu W, Li L, Yang J, Li P, Hu Y, Zhang G, Zhu X. Therapeutic Effect of Biejiaxiaozheng Pills on Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats through the NF-κB/Nrf2 Pathway. Gastroenterol Res Pract 2021;2021:3954244. [PMID: 34868305 DOI: 10.1155/2021/3954244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
146 Vinken M. Gap junctions and non-neoplastic liver disease. Journal of Hepatology 2012;57:655-62. [DOI: 10.1016/j.jhep.2012.02.036] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
147 Swiderska-Syn M, Suzuki A, Guy CD, Schwimmer JB, Abdelmalek MF, Lavine JE, Diehl AM. Hedgehog pathway and pediatric nonalcoholic fatty liver disease. Hepatology 2013;57:1814-25. [PMID: 23300059 DOI: 10.1002/hep.26230] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
148 Li Q, Li H, Lv Y, Zhang Q, Zhang X, Li S, Zheng X, Wang Y, Hao Z. Hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP) confers protection against hepatic fibrosis through downregulation of transforming growth factor β receptor II. Lab Invest 2020;100:466-82. [PMID: 31641222 DOI: 10.1038/s41374-019-0314-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
149 Wang Z, Ai X, Zhang Z, Wang Y, Wu X, Haindl R, Yeow EKL, Drexler W, Gao M, Xing B. NIR nanoprobe-facilitated cross-referencing manifestation of local disease biology for dynamic therapeutic response assessment. Chem Sci 2019;11:803-11. [PMID: 34123056 DOI: 10.1039/c9sc04909f] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 3.3] [Reference Citation Analysis]
150 Friedman JE, Dobrinskikh E, Alfonso-Garcia A, Fast A, Janssen RC, Soderborg TK, Anderson AL, Reisz JA, D'Alessandro A, Frank DN, Robertson CE, de la Houssaye BA, Johnson LK, Orlicky DJ, Wang XX, Levi M, Potma EO, El Kasmi KC, Jonscher KR. Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice. Hepatol Commun 2018;2:313-28. [PMID: 29507905 DOI: 10.1002/hep4.1139] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
151 Gao W, Sun J, Wang F, Lu Y, Wen C, Bian Q, Wu H. Deoxyelephantopin suppresses hepatic stellate cells activation associated with inhibition of aerobic glycolysis via hedgehog pathway. Biochem Biophys Res Commun 2019;516:1222-8. [PMID: 31296386 DOI: 10.1016/j.bbrc.2019.07.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
152 Halder S, Islam A, Muhit MA, Shill MC, Haider SS. Self-emulsifying drug delivery system of black seed oil with improved hypotriglyceridemic effect and enhanced hepatoprotective function. Journal of Functional Foods 2021;78:104391. [DOI: 10.1016/j.jff.2021.104391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
153 He Y, Wu YT, Huang C, Meng XM, Ma TT, Wu BM, Xu FY, Zhang L, Lv XW, Li J. Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis. Biochim Biophys Acta. 2014;1842:2204-2215. [PMID: 25201080 DOI: 10.1016/j.bbadis.2014.08.015] [Cited by in Crossref: 102] [Cited by in F6Publishing: 103] [Article Influence: 12.8] [Reference Citation Analysis]
154 Sohrabpour AA, Mohamadnejad M, Malekzadeh R. Review article: the reversibility of cirrhosis. Aliment Pharmacol Ther 2012;36:824-32. [PMID: 22966946 DOI: 10.1111/apt.12044] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
155 Ho CH, Huang JH, Sun MS, Tzeng IS, Hsu YC, Kuo CY. Wild Bitter Melon Extract Regulates LPS-Induced Hepatic Stellate Cell Activation, Inflammation, Endoplasmic Reticulum Stress, and Ferroptosis. Evid Based Complement Alternat Med 2021;2021:6671129. [PMID: 34239589 DOI: 10.1155/2021/6671129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Böttcher K, Pinzani M. Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents. Adv Drug Deliv Rev 2017;121:3-8. [PMID: 28600202 DOI: 10.1016/j.addr.2017.05.016] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 13.8] [Reference Citation Analysis]
157 Sun L, Wang Y, Cen J, Ma X, Cui L, Qiu Z, Zhang Z, Li H, Yang RZ, Wang C, Chen X, Wang L, Ye Y, Zhang H, Pan G, Kang JS, Ji Y, Zheng YW, Zheng S, Hui L. Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes. Nat Cell Biol. 2019;21:1015-1026. [PMID: 31332348 DOI: 10.1038/s41556-019-0359-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
158 Guo XH, Liu LX, Zhang HY, Zhang QQ, Li Y, Tian XX, Qiu ZH. Insulin-like growth factor binding protein-related protein 1 contributes to hepatic fibrogenesis. J Dig Dis. 2014;15:202-210. [PMID: 24373620 DOI: 10.1111/1751-2980.12126] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
159 Tao YY, Yan XC, Zhou T, Shen L, Liu ZL, Liu CH. Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis. BMC Complement Altern Med 2014;14:449. [PMID: 25407538 DOI: 10.1186/1472-6882-14-449] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
160 Okwor CIA, Oh JS, Crawley AM, Cooper CL, Lee SH. Expression of Inhibitory Receptors on T and NK Cells Defines Immunological Phenotypes of HCV Patients with Advanced Liver Fibrosis. iScience 2020;23:101513. [PMID: 32920488 DOI: 10.1016/j.isci.2020.101513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
161 Matsuzaki K. Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells. Cell Tissue Res 2012;347:225-43. [PMID: 21626291 DOI: 10.1007/s00441-011-1178-6] [Cited by in Crossref: 48] [Cited by in F6Publishing: 59] [Article Influence: 4.4] [Reference Citation Analysis]
162 Carotti S, Perrone G, Amato M, Vespasiani Gentilucci U, Righi D, Francesconi M, Pellegrini C, Zalfa F, Zingariello M, Picardi A, Onetti Muda A, Morini S. Reelin expression in human liver of patients with chronic hepatitis C infection. Eur J Histochem 2017;61:2745. [PMID: 28348420 DOI: 10.4081/ejh.2017.2745] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
163 Bubnov RV, Drahulian MV, Buchek PV, Gulko TP. High regenerative capacity of the liver and irreversible injury of male reproductive system in carbon tetrachloride-induced liver fibrosis rat model. EPMA J 2018;9:59-75. [PMID: 29515688 DOI: 10.1007/s13167-017-0115-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
164 Yu K, Li N, Cheng Q, Zheng J, Zhu M, Bao S, Chen M, Shi G. miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7. J Mol Med (Berl) 2018;96:65-74. [PMID: 29051972 DOI: 10.1007/s00109-017-1593-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
165 Moll S, Chaykovska L, Meier M, Budd DC, Formentini I, Pomposiello S, Prunotto M. Targeting the epithelial cells in fibrosis: a new concept for an old disease. Drug Discov Today 2013;18:582-91. [PMID: 23348679 DOI: 10.1016/j.drudis.2013.01.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
166 Ding Q, Li Z, Liu B, Ling L, Tian X, Zhang C. Propranolol prevents liver cirrhosis by inhibiting hepatic stellate cell activation mediated by the PDGFR/Akt pathway. Hum Pathol 2018;76:37-46. [PMID: 29514109 DOI: 10.1016/j.humpath.2018.02.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
167 El-mansy A, Mazroa S, Hamed W, Yaseen A, El-mohandes E. Histological and immunohistochemical effects of Curcuma longa on activation of rat hepatic stellate cells after cadmium induced hepatotoxicity. Biotechnic & Histochemistry 2016;91:170-81. [DOI: 10.3109/10520295.2015.1116048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
168 Crespo I, San-Miguel B, Fernández A, Ortiz de Urbina J, González-Gallego J, Tuñón MJ. Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice. Transl Res 2015;165:346-57. [PMID: 25445210 DOI: 10.1016/j.trsl.2014.10.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
169 Hong Y, Yao Q, Zheng L. Thymosin β4 attenuates liver fibrosis via suppressing Notch signaling. Biochem Biophys Res Commun 2017;493:1396-401. [PMID: 28965947 DOI: 10.1016/j.bbrc.2017.09.156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
170 Lee JM, Seo YS, Kim TH, Ahn JM, Yim SY, Kim SU, Jung YK, Kim JH, An H, Yim HJ, Yeon JE, Lee HS, Byun KS, Um SH, Kim CD, Ryu HS. The LAW index as an accurate indicator of the initiation of antiviral treatment in patients with chronic hepatitis B. J Gastroenterol Hepatol 2017;32:208-14. [PMID: 27194632 DOI: 10.1111/jgh.13447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
171 Kumar P, Smith T, Rahman K, Mells JE, Thorn NE, Saxena NK, Anania FA. Adiponectin modulates focal adhesion disassembly in activated hepatic stellate cells: implication for reversing hepatic fibrosis. FASEB J. 2014;28:5172-5183. [PMID: 25154876 DOI: 10.1096/fj.14-253229] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
172 Rockey DC, Friedman SL. Hepatic Fibrosis and Cirrhosis. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 64-85. [DOI: 10.1016/b978-1-4377-0881-3.00005-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
173 Tan H, He Q, Li R, Lei F, Lei X. Trillin Reduces Liver Chronic Inflammation and Fibrosis in Carbon Tetrachloride (CCl4) Induced Liver Injury in Mice. Immunol Invest 2016;45:371-82. [PMID: 27219527 DOI: 10.3109/08820139.2015.1137935] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
174 Chen J, Li X, Hu Y, Liu W, Zhou Q, Zhang H, Mu Y, Liu P. Gypenosides Ameliorate Carbon Tetrachloride-Induced Liver Fibrosis by Inhibiting the Differentiation of Hepatic Progenitor Cells into Myofibroblasts. Am J Chin Med 2017;45:1061-74. [DOI: 10.1142/s0192415x17500574] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
175 Yang L, Liu Y, Sun Y, Huang C, Li J, Wang Y. New advances of DNA/RNA methylation modification in liver fibrosis. Cell Signal 2021;:110224. [PMID: 34954394 DOI: 10.1016/j.cellsig.2021.110224] [Reference Citation Analysis]
176 Wan Y, Tang MH, Chen XC, Chen LJ, Wei YQ, Wang YS. Inhibitory effect of liposomal quercetin on acute hepatitis and hepatic fibrosis induced by concanavalin A. Braz J Med Biol Res 2014;47:655-61. [PMID: 25098714 DOI: 10.1590/1414-431x20143704] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
177 Claveria-Cabello A, Colyn L, Uriarte I, Latasa MU, Arechederra M, Herranz JM, Alvarez L, Urman JM, Martinez-Chantar ML, Banales JM, Sangro B, Rombouts K, Oyarzabal J, Marin JJG, Berasain C, Avila MA, Fernandez-Barrena MG. Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis. Cancers (Basel) 2020;12:E3748. [PMID: 33322158 DOI: 10.3390/cancers12123748] [Reference Citation Analysis]
178 Berasain C, Avila MA. Regulation of hepatocyte identity and quiescence. Cell Mol Life Sci 2015;72:3831-51. [DOI: 10.1007/s00018-015-1970-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
179 Yu L, Wang L, Wu X, Yi H. RSPO4-CRISPR alleviates liver injury and restores gut microbiota in a rat model of liver fibrosis. Commun Biol 2021;4:230. [PMID: 33603089 DOI: 10.1038/s42003-021-01747-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Quetglas IM, Moeini A, Pinyol R, Llovet JM. Integration of genomic information in the clinical management of HCC. Best Pract Res Clin Gastroenterol 2014;28:831-42. [PMID: 25260311 DOI: 10.1016/j.bpg.2014.08.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
181 Kim RS, Hasegawa D, Goossens N, Tsuchida T, Athwal V, Sun X, Robinson CL, Bhattacharya D, Chou HI, Zhang DY, Fuchs BC, Lee Y, Hoshida Y, Friedman SL. The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy. Sci Rep. 2016;6:39342. [PMID: 27996033 DOI: 10.1038/srep39342] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
182 Perugorria MJ, Esparza-Baquer A, Oakley F, Labiano I, Korosec A, Jais A, Mann J, Tiniakos D, Santos-Laso A, Arbelaiz A, Gawish R, Sampedro A, Fontanellas A, Hijona E, Jimenez-Agüero R, Esterbauer H, Stoiber D, Bujanda L, Banales JM, Knapp S, Sharif O, Mann DA. Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage. Gut 2019;68:533-46. [PMID: 29374630 DOI: 10.1136/gutjnl-2017-314107] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 15.7] [Reference Citation Analysis]
183 Zheng S, Chen Y, Guo J, Qi D, Zheng S, Zhang S, Weng Z. Recombinant adeno-associated virus-mediated transfer of shRNA against Notch3 ameliorates hepatic fibrosis in rats. Exp Biol Med (Maywood) 2013;238:600-9. [DOI: 10.1177/1535370213480698] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
184 Tian W, Hao C, Fan Z, Weng X, Qin H, Wu X, Fang M, Chen Q, Shen A, Xu Y. Myocardin related transcription factor A programs epigenetic activation of hepatic stellate cells. J Hepatol 2015;62:165-74. [PMID: 25109772 DOI: 10.1016/j.jhep.2014.07.029] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 6.5] [Reference Citation Analysis]
185 Gajendiran P, Vega LI, Itoh K, Sesaki H, Vakili MR, Lavasanifar A, Hong K, Mezey E, Ganapathy-Kanniappan S. Elevated mitochondrial activity distinguishes fibrogenic hepatic stellate cells and sensitizes for selective inhibition by mitotropic doxorubicin. J Cell Mol Med 2018;22:2210-9. [PMID: 29397578 DOI: 10.1111/jcmm.13501] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
186 Chen Y, Huang Y, Reiberger T, Duyverman AM, Huang P, Samuel R, Hiddingh L, Roberge S, Koppel C, Lauwers GY, Zhu AX, Jain RK, Duda DG. Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice. Hepatology 2014;59:1435-47. [PMID: 24242874 DOI: 10.1002/hep.26790] [Cited by in Crossref: 130] [Cited by in F6Publishing: 125] [Article Influence: 16.3] [Reference Citation Analysis]
187 Towbin AJ, Serai SD, Podberesky DJ. Magnetic resonance imaging of the pediatric liver: imaging of steatosis, iron deposition, and fibrosis. Magn Reson Imaging Clin N Am. 2013;21:669-680. [PMID: 24183519 DOI: 10.1016/j.mric.2013.05.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
188 McHedlidze T, Waldner M, Zopf S, Walker J, Rankin AL, Schuchmann M, Voehringer D, McKenzie AN, Neurath MF, Pflanz S. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity. 2013;39:357-371. [PMID: 23954132 DOI: 10.1016/j.immuni.2013.07.018] [Cited by in Crossref: 312] [Cited by in F6Publishing: 305] [Article Influence: 34.7] [Reference Citation Analysis]
189 Chen PJ, Huang C, Meng XM, Li J. Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis. Biochimie 2015;116:61-9. [PMID: 26116886 DOI: 10.1016/j.biochi.2015.06.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
190 Lyu H, Wang H, Li L, Zhu J, Chen F, Chen Y, Liu C, Fu J, Yang B, Zhang Q, Xu Y, Pi J. Hepatocyte-specific deficiency of Nrf2 exacerbates carbon tetrachloride-induced liver fibrosis via aggravated hepatocyte injury and subsequent inflammatory and fibrogenic responses. Free Radical Biology and Medicine 2020;150:136-47. [DOI: 10.1016/j.freeradbiomed.2020.02.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
191 Ceccarelli S, Panera N, Gnani D, Nobili V. Dual Role of MicroRNAs in NAFLD. Int J Mol Sci. 2013;14:8437-8455. [PMID: 23594995 DOI: 10.3390/ijms14048437] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
192 Deng X, Zhang X, Li W, Feng RX, Li L, Yi GR, Zhang XN, Yin C, Yu HY, Zhang JP, Lu B, Hui L, Xie WF. Chronic Liver Injury Induces Conversion of Biliary Epithelial Cells into Hepatocytes. Cell Stem Cell. 2018;23:114-122.e3. [PMID: 29937200 DOI: 10.1016/j.stem.2018.05.022] [Cited by in Crossref: 101] [Cited by in F6Publishing: 91] [Article Influence: 25.3] [Reference Citation Analysis]
193 Zhao H, Wang Z, Tang F, Zhao Y, Feng D, Li Y, Hu Y, Wang C, Zhou J, Tian X, Yao J. Carnosol-mediated Sirtuin 1 activation inhibits Enhancer of Zeste Homolog 2 to attenuate liver fibrosis. Pharmacol Res 2018;128:327-37. [PMID: 29106960 DOI: 10.1016/j.phrs.2017.10.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
194 Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis. Oncotarget 2017;8:90579-604. [PMID: 29163854 DOI: 10.18632/oncotarget.21234] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 15.8] [Reference Citation Analysis]
195 Chen RJ, Wu HH, Wang YJ. Strategies to prevent and reverse liver fibrosis in humans and laboratory animals. Arch Toxicol. 2015;89:1727-1750. [PMID: 25963329 DOI: 10.1007/s00204-015-1525-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
196 Mezaki Y, Morii M, Hebiguchi T, Yoshikawa K, Yamaguchi N, Miura M, Imai K, Yoshino H, Senoo H. Differential increases in the expression of intermediate filament proteins and concomitant morphological changes of transdifferentiating rat hepatic stellate cells observed in vitro. Acta Histochem Cytochem 2013;46:137-43. [PMID: 24194627 DOI: 10.1267/ahc.13007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
197 Nunoya J, Washburn ML, Kovalev GI, Su L. Regulatory T cells prevent liver fibrosis during HIV type 1 infection in a humanized mouse model. J Infect Dis 2014;209:1039-44. [PMID: 24133182 DOI: 10.1093/infdis/jit548] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
198 Wang C, Deng J, Deng H, Kang Z, Huang Z, Ding Z, Dong L, Chen J, Zhang J, Zang Y. A Novel Sox9/lncRNA H19 Axis Contributes to Hepatocyte Death and Liver Fibrosis. Toxicol Sci 2020;177:214-25. [PMID: 32579217 DOI: 10.1093/toxsci/kfaa097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
199 Cheng C, Huang C, Ma T, Xu T, Wang Y, Zhang L, Jun L. New surprises of suppressor of cytokine signalling in liver fibrosis. Expert Opinion on Therapeutic Targets 2014;18:415-26. [DOI: 10.1517/14728222.2014.885953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
200 Elias MB, Oliveira FL, Guma FCR, Martucci RB, Borojevic R, Teodoro AJ. Lycopene inhibits hepatic stellate cell activation and modulates cellular lipid storage and signaling. Food Funct 2019;10:1974-84. [PMID: 30889234 DOI: 10.1039/c8fo02369g] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
201 Grebely J, Talwalkar JA. Recognizing and preventing death from compensated cirrhosis in the community. Liver Int 2012;32:2-4. [PMID: 22098367 DOI: 10.1111/j.1478-3231.2011.02627.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
202 Wang J, Chen X, Zhang C, Tao L, Zhang Z, Liu X, Xu Y, Wang H, Li J, Xu D. Phenylbutyric acid protects against carbon tetrachloride-induced hepatic fibrogenesis in mice. Toxicology and Applied Pharmacology 2013;266:307-16. [DOI: 10.1016/j.taap.2012.11.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
203 Ahsan MK, Mehal WZ. Activation of adenosine receptor A2A increases HSC proliferation and inhibits death and senescence by down-regulation of p53 and Rb. Front Pharmacol. 2014;5:69. [PMID: 24782773 DOI: 10.3389/fphar.2014.00069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
204 Bae JS, Park JM, Lee J, Oh BC, Jang SH, Lee YB, Han YM, Ock CY, Cha JY, Hahm KB. Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice. Metabolism 2017;66:32-44. [PMID: 27923447 DOI: 10.1016/j.metabol.2016.10.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
205 Hoshida Y, Villanueva A, Sangiovanni A, Sole M, Hur C, Andersson KL, Chung RT, Gould J, Kojima K, Gupta S, Taylor B, Crenshaw A, Gabriel S, Minguez B, Iavarone M, Friedman SL, Colombo M, Llovet JM, Golub TR. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology 2013;144:1024-30. [PMID: 23333348 DOI: 10.1053/j.gastro.2013.01.021] [Cited by in Crossref: 125] [Cited by in F6Publishing: 121] [Article Influence: 13.9] [Reference Citation Analysis]
206 Martínez-Urbistondo D, de la Garza RG, Villares-Fernández P, Font C, Schellong S, López-Núñez JJ, Gil-Díaz A, Del Carmen Díaz-Pedroche M, Hirmerova J, Monreal M; RIETE Investigators. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism. Intern Emerg Med 2021. [PMID: 34626318 DOI: 10.1007/s11739-021-02858-x] [Reference Citation Analysis]
207 . Liver. Canine and Feline Gastroenterology. Elsevier; 2013. pp. 849-957. [DOI: 10.1016/b978-1-4160-3661-6.00061-4] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
208 Yang YL, Wang FS, Li SC, Tiao MM, Huang YH. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases. Int J Mol Sci 2017;18:E192. [PMID: 28106784 DOI: 10.3390/ijms18010192] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
209 Li SC, Wang FS, Yang YL, Tiao MM, Chuang JH, Huang YH. Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries. Int J Mol Sci 2016;17:324. [PMID: 26938532 DOI: 10.3390/ijms17030324] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
210 Longxi P, Buwu F, Yuan W, Sinan G. Expression of p53 in the effects of artesunate on induction of apoptosis and inhibition of proliferation in rat primary hepatic stellate cells. PLoS One 2011;6:e26500. [PMID: 22053192 DOI: 10.1371/journal.pone.0026500] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
211 Ren JJ, Huang TJ, Zhang QQ, Zhang HY, Guo XH, Fan HQ, Li RK, Liu LX. Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice. Hepatobiliary Pancreat Dis Int 2019;18:38-47. [PMID: 30243878 DOI: 10.1016/j.hbpd.2018.08.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
212 Bhatia SN, Underhill GH, Zaret KS, Fox IJ. Cell and tissue engineering for liver disease. Sci Transl Med. 2014;6:245sr2. [PMID: 25031271 DOI: 10.1126/scitranslmed.3005975] [Cited by in Crossref: 178] [Cited by in F6Publishing: 167] [Article Influence: 25.4] [Reference Citation Analysis]
213 Halder S, Mibe Y, Rikimura S, Kuromi K, Sato H, Onoue S. Strategic application of liposomal system to R-α-lipoic acid for improvement of nutraceutical properties. Drug Dev Ind Pharm 2022;:1-12. [PMID: 35875919 DOI: 10.1080/03639045.2022.2105865] [Reference Citation Analysis]
214 Feng R, Du W, Lui P, Zhang J, Liu Y. CAPN2 acts as an indicator of hepatitis B virus to induce hepatic fibrosis. J Cell Biochem 2020;121:2428-36. [PMID: 31680308 DOI: 10.1002/jcb.29465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
215 Pinzani M. Hepatic Fibrosis. Stellate Cells in Health and Disease. Elsevier; 2015. pp. 29-39. [DOI: 10.1016/b978-0-12-800134-9.00003-8] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
216 Yeh YH, Liang CY, Chen ML, Tsai FM, Lin YY, Lee MC, Wu JS, Kuo CY. Apoptotic effects of hsian-tsao (Mesona procumbens Hemsley) on hepatic stellate cells mediated by reactive oxygen species and ERK, JNK, and caspase-3 pathways. Food Sci Nutr 2019;7:1891-8. [PMID: 31139404 DOI: 10.1002/fsn3.1046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
217 Ribatti D, Tamma R. Giulio Gabbiani and the discovery of myofibroblasts. Inflamm Res 2019;68:241-5. [PMID: 30610292 DOI: 10.1007/s00011-018-01211-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
218 Wan Y, Wu YL, Lian LH, Xie WX, Li X, Ouyang BQ, Bai T, Li Q, Yang N, Nan JX. The anti-fibrotic effect of betulinic acid is mediated through the inhibition of NF-κB nuclear protein translocation. Chem Biol Interact. 2012;195:215-223. [PMID: 22285267 DOI: 10.1016/j.cbi.2012.01.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
219 Hatori A, Yui J, Xie L, Kumata K, Yamasaki T, Fujinaga M, Wakizaka H, Ogawa M, Nengaki N, Kawamura K, Wang F, Zhang MR. Utility of Translocator Protein (18 kDa) as a Molecular Imaging Biomarker to Monitor the Progression of Liver Fibrosis. Sci Rep 2015;5:17327. [PMID: 26612465 DOI: 10.1038/srep17327] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
220 He Y, Huang C, Zhang SP, Sun X, Long XR, Li J. The potential of microRNAs in liver fibrosis. Cell Signal. 2012;24:2268-2272. [PMID: 22884954 DOI: 10.1016/j.cellsig.2012.07.023] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 8.3] [Reference Citation Analysis]
221 Yang L, Seki E. Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms. Front Physiol 2012;3:138. [PMID: 22661952 DOI: 10.3389/fphys.2012.00138] [Cited by in Crossref: 80] [Cited by in F6Publishing: 92] [Article Influence: 8.0] [Reference Citation Analysis]
222 Meng T, Xiao D, Muhammed A, Deng J, Chen L, He J. Anti-Inflammatory Action and Mechanisms of Resveratrol. Molecules 2021;26:E229. [PMID: 33466247 DOI: 10.3390/molecules26010229] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
223 Dooley S, ten Dijke P. TGF-β in progression of liver disease. Cell Tissue Res. 2012;347:245-256. [PMID: 22006249 DOI: 10.1007/s00441-011-1246-y] [Cited by in Crossref: 409] [Cited by in F6Publishing: 419] [Article Influence: 37.2] [Reference Citation Analysis]
224 Wu CF, Lin YL, Huang YT. Hepatitis C virus core protein stimulates fibrogenesis in hepatic stellate cells involving the obese receptor. J Cell Biochem. 2013;114:541-550. [PMID: 22961938 DOI: 10.1002/jcb.24392] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
225 Sung YC, Liu YC, Chao PH, Chang CC, Jin PR, Lin TT, Lin JA, Cheng HT, Wang J, Lai CP, Chen LH, Wu AY, Ho TL, Chiang T, Gao DY, Duda DG, Chen Y. Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development. Theranostics 2018;8:894-905. [PMID: 29463989 DOI: 10.7150/thno.21168] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 12.3] [Reference Citation Analysis]
226 Trivella JP, Martin P, Carrion AF. Novel targeted therapies for the management of liver fibrosis. Expert Opinion on Emerging Drugs 2020;25:59-70. [DOI: 10.1080/14728214.2020.1735350] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
227 Iwasaki A, Sakai K, Moriya K, Sasaki T, Keene DR, Akhtar R, Miyazono T, Yasumura S, Watanabe M, Morishita S, Sakai T. Molecular Mechanism Responsible for Fibronectin-controlled Alterations in Matrix Stiffness in Advanced Chronic Liver Fibrogenesis. J Biol Chem 2016;291:72-88. [PMID: 26553870 DOI: 10.1074/jbc.M115.691519] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
228 Yu F, Guo Y, Chen B, Dong P, Zheng J. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Lab Invest. 2015;95:781-789. [PMID: 25915722 DOI: 10.1038/labinvest.2015.58] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
229 Kogure T, Costinean S, Yan I, Braconi C, Croce C, Patel T. Hepatic miR-29ab1 expression modulates chronic hepatic injury. J Cell Mol Med. 2012;16:2647-2654. [PMID: 22469499 DOI: 10.1111/j.1582-4934.2012.01578.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
230 Andueza A, Garde N, García-Garzón A, Ansorena E, López-Zabalza MJ, Iraburu MJ, Zalba G, Martínez-Irujo JJ. NADPH oxidase 5 promotes proliferation and fibrosis in human hepatic stellate cells. Free Radic Biol Med 2018;126:15-26. [PMID: 30036633 DOI: 10.1016/j.freeradbiomed.2018.07.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
231 Piao RL, Brigstock DR, Zhu J, Zhang ML, Gao RP. Clinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis. World J Gastroenterol 2012; 18(18): 2280-2286 [PMID: 22611323 DOI: 10.3748/wjg.v18.i18.2280] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
232 Habash NW, Sehrawat TS, Shah VH, Cao S. Epigenetics of Alcohol-Related Liver Diseases. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
233 Ullah A, Chen G, Hussain A, Khan H, Abbas A, Zhou Z, Shafiq M, Ahmad S, Ali U, Usman M, Raza F, Ahmed A, Qiu Z, Zheng M, Liu D. Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis. Int J Nanomedicine 2021;16:4451-70. [PMID: 34234436 DOI: 10.2147/IJN.S314367] [Reference Citation Analysis]
234 An P, Wei LL, Zhao S, Sverdlov DY, Vaid KA, Miyamoto M, Kuramitsu K, Lai M, Popov YV. Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. Nat Commun 2020;11:2362. [PMID: 32398673 DOI: 10.1038/s41467-020-16092-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
235 Liu Y, Abudounnasier G, Zhang T, Liu X, Wang Q, Yan Y, Ding J, Wen H, Yimiti D, Ma X. Increased Expression of TGF-β1 in Correlation with Liver Fibrosis during Echinococcus granulosus Infection in Mice. Korean J Parasitol 2016;54:519-25. [PMID: 27658605 DOI: 10.3347/kjp.2016.54.4.519] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
236 Aldámiz-Echevarría T, Resino S, Bellón JM, Jiménez-Sousa MA, Miralles P, Medrano LM, Carrero A, Díez C, Pérez-Latorre L, Fanciulli C, Garcia-Broncano P, Berenguer J. European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study. J Transl Med 2019;17:244. [PMID: 31349790 DOI: 10.1186/s12967-019-1997-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
237 Jang E, Kim BJ, Lee KT, Inn KS, Lee JH. A Survey of Therapeutic Effects of Artemisia capillaris in Liver Diseases. Evid Based Complement Alternat Med 2015;2015:728137. [PMID: 26366183 DOI: 10.1155/2015/728137] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
238 Kim DK, Yoon H, Han K, Kim J, Lee MJ, Kim S, Koh H, Han SJ, Shin HJ. Effect of different driver power amplitudes on liver stiffness measurement in pediatric liver MR elastography. Abdom Radiol (NY) 2021;46:4729-35. [PMID: 34216244 DOI: 10.1007/s00261-021-03197-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Wilson SE. TGF beta -1, -2 and -3 in the modulation of fibrosis in the cornea and other organs. Exp Eye Res 2021;207:108594. [PMID: 33894227 DOI: 10.1016/j.exer.2021.108594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
240 Yoshida K, Matsuzaki K. Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries. Front Physiol. 2012;3:53. [PMID: 22457652 DOI: 10.3389/fphys.2012.00053] [Cited by in Crossref: 76] [Cited by in F6Publishing: 74] [Article Influence: 7.6] [Reference Citation Analysis]
241 Zhang HJ, Wu JF, Liu CB. Plasticity of hepatic stellate cells: implications for the treatment of hepatic fibrosis. Shijie Huaren Xiaohua Zazhi 2011; 19(33): 3415-3419 [DOI: 10.11569/wcjd.v19.i33.3415] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
242 Fausther M, Goree JR, Lavoie ÉG, Graham AL, Sévigny J, Dranoff JA. Establishment and characterization of rat portal myofibroblast cell lines. PLoS One 2015;10:e0121161. [PMID: 25822334 DOI: 10.1371/journal.pone.0121161] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
243 Yang CH, Ting WJ, Day CH, Ju DT, Yeh YL, Chung LC, Tsai FJ, Tsai CH, Tsai Y, Huang CY. SHSST cyclodextrin complex prevents the fibrosis effect on CCl4-induced cirrhotic cardiomyopathy in rats through TGF-β pathway inhibition effects. Int J Mol Sci. 2014;15:8037-8048. [PMID: 24815066 DOI: 10.3390/ijms15058037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
244 Sun Z, Sun D, Wang F, Cheng K, Zhang Z, Xu B, Ye M, Wang L, Zou H. Differential analysis of N-glycoproteome between hepatocellular carcinoma and normal human liver tissues by combination of multiple protease digestion and solid phase based labeling. Clin Proteomics 2014;11:26. [PMID: 25097464 DOI: 10.1186/1559-0275-11-26] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
245 She L, Xu D, Wang Z, Zhang Y, Wei Q, Aa J, Wang G, Liu B, Xie Y. Curcumin inhibits hepatic stellate cell activation via suppression of succinate-associated HIF-1α induction. Mol Cell Endocrinol 2018;476:129-38. [PMID: 29746885 DOI: 10.1016/j.mce.2018.05.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
246 Huang YH, Yang YL, Wang FS. The Role of miR-29a in the Regulation, Function, and Signaling of Liver Fibrosis. Int J Mol Sci 2018;19:E1889. [PMID: 29954104 DOI: 10.3390/ijms19071889] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
247 Wu X, Zhang F, Xiong X, Lu C, Lian N, Lu Y, Zheng S. Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP3 inflammasome pathway. IUBMB Life. 2015;67:312-321. [PMID: 25847612 DOI: 10.1002/iub.1348] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
248 Li X, Wu XQ, Xu T, Li XF, Yang Y, Li WX, Huang C, Meng XM, Li J. Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis. Toxicol Appl Pharmacol 2016;306:58-68. [PMID: 27396813 DOI: 10.1016/j.taap.2016.07.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
249 King LY, Canasto-Chibuque C, Johnson KB, Yip S, Chen X, Kojima K, Deshmukh M, Venkatesh A, Tan PS, Sun X, Villanueva A, Sangiovanni A, Nair V, Mahajan M, Kobayashi M, Kumada H, Iavarone M, Colombo M, Fiel MI, Friedman SL, Llovet JM, Chung RT, Hoshida Y. A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration. Gut 2015;64:1296-302. [PMID: 25143343 DOI: 10.1136/gutjnl-2014-307862] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
250 Borkham-Kamphorst E, Huss S, Van de Leur E, Haas U, Weiskirchen R. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis. Liver Int 2012;32:1342-53. [PMID: 22698069 DOI: 10.1111/j.1478-3231.2012.02837.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
251 Puente A, Fortea JI, Cabezas J, Arias Loste MT, Iruzubieta P, Llerena S, Huelin P, Fábrega E, Crespo J. LOXL2-A New Target in Antifibrogenic Therapy? Int J Mol Sci 2019;20:E1634. [PMID: 30986934 DOI: 10.3390/ijms20071634] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
252 Kim YO, Popov Y, Schuppan D. Optimized Mouse Models for Liver Fibrosis. Methods Mol Biol. 2017;1559:279-296. [PMID: 28063051 DOI: 10.1007/978-1-4939-6786-5_19] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
253 Li ZJ, Ou-Yang PH, Han XP. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells. Cell Signal. 2014;26:141-148. [PMID: 24100264 DOI: 10.1016/j.cellsig.2013.09.018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
254 Louka ML, Ramzy MM. Involvement of fibroblast-specific protein 1 (S100A4) and matrix metalloproteinase-13 (MMP-13) in CCl4-induced reversible liver fibrosis. Gene 2016;579:29-33. [PMID: 26721462 DOI: 10.1016/j.gene.2015.12.042] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
255 Dranoff JA, Feld JJ, Lavoie EG, Fausther M. How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations. Hepatology 2014;60:464-7. [PMID: 24464631 DOI: 10.1002/hep.27032] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
256 Yang J, Xu C, Wu M, Wu Y, Jia X, Zhou C, Zhang X, Ge S, Li Z, Zhang L. MicroRNA-124 inhibits hepatic stellate cells inflammatory cytokines secretion by targeting IQGAP1 through NF-κB pathway. Int Immunopharmacol 2021;95:107520. [PMID: 33743313 DOI: 10.1016/j.intimp.2021.107520] [Reference Citation Analysis]
257 Men R, Wen M, Dan X, Zhu Y, Wang W, Li J, Wu W, Liu X, Yang L. Nogo-B: A potential indicator for hepatic cirrhosis and regulator in hepatic stellate cell activation. Hepatol Res. 2015;45:113-122. [PMID: 24606149 DOI: 10.1111/hepr.12324] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
258 Cai FF, Bian YQ, Wu R, Sun Y, Chen XL, Yang MD, Zhang QR, Hu Y, Sun MY, Su SB. Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis. Biomed Pharmacother 2019;114:108863. [PMID: 30991286 DOI: 10.1016/j.biopha.2019.108863] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
259 Wu L, Mao C, Ming X. Modulation of Bcl-x Alternative Splicing Induces Apoptosis of Human Hepatic Stellate Cells. Biomed Res Int. 2016;2016:7478650. [PMID: 27579319 DOI: 10.1155/2016/7478650] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
260 Ikenaga N, Liu SB, Sverdlov DY, Yoshida S, Nasser I, Ke Q, Kang PM, Popov Y. A new Mdr2(-/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer. Am J Pathol 2015;185:325-34. [PMID: 25478810 DOI: 10.1016/j.ajpath.2014.10.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
261 Yoshida K, Matsuzaki K. Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries. Front Physiol. 2012;3:53. [PMID: 22457652 DOI: 10.3389/fphys]] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
262 Wang L, Yue Z, Guo M, Fang L, Bai L, Li X, Tao Y, Wang S, Liu Q, Zhi D, Zhao H. Dietary Flavonoid Hyperoside Induces Apoptosis of Activated Human LX-2 Hepatic Stellate Cell by Suppressing Canonical NF-κB Signaling. Biomed Res Int 2016;2016:1068528. [PMID: 27110557 DOI: 10.1155/2016/1068528] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
263 Lv F, Li N, Kong M, Wu J, Fan Z, Miao D, Xu Y, Ye Q, Wang Y. CDKN2a/p16 Antagonizes Hepatic Stellate Cell Activation and Liver Fibrosis by Modulating ROS Levels. Front Cell Dev Biol 2020;8:176. [PMID: 32266258 DOI: 10.3389/fcell.2020.00176] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
264 Vinken M. Adverse Outcome Pathways and Drug-Induced Liver Injury Testing. Chem Res Toxicol 2015;28:1391-7. [PMID: 26119269 DOI: 10.1021/acs.chemrestox.5b00208] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 7.7] [Reference Citation Analysis]
265 Fan TT, Hu PF, Wang J, Wei J, Zhang Q, Ning BF, Yin C, Zhang X, Xie WF, Chen YX, Shi B. Regression effect of hepatocyte nuclear factor 4α on liver cirrhosis in rats. J Dig Dis 2013;14:318-27. [PMID: 23374293 DOI: 10.1111/1751-2980.12042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
266 Yin X, Yi H, Wang L, Wu W, Wu X, Yu L. RSPOs facilitated HSC activation and promoted hepatic fibrogenesis. Oncotarget 2016;7:63767-78. [PMID: 27572318 DOI: 10.18632/oncotarget.11654] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
267 Huang J, Tao R, Li L, Ma K, Xu L, Ai G, Fan X, Jiao Y, Ning Q. Involvement of heat shock protein 47 in Schistosoma japonicum-induced hepatic fibrosis in mice. International Journal for Parasitology 2014;44:23-35. [DOI: 10.1016/j.ijpara.2013.08.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
268 Alisi A, Arciello M, Petrini S, Conti B, Missale G, Balsano C. Focal adhesion kinase (FAK) mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)-infected cells. PLoS One. 2012;7:e44147. [PMID: 22937161 DOI: 10.1371/journal.pone.0044147] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
269 Jiménez-Sousa MA, Berenguer J, Fernández-Rodríguez A, Medrano LM, Aldámiz-Echevarria T, Pérez-Latorre L, Díez C, Martín-Vicente M, Gutiérrez-Rivas M, Martínez I, Resino S. Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study. Infect Genet Evol 2019;67:112-20. [PMID: 30336268 DOI: 10.1016/j.meegid.2018.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
270 Patel K, Shackel NA. Current status of fibrosis markers. Curr Opin Gastroenterol. 2014;30:253-259. [PMID: 24671009 DOI: 10.1097/mog.0000000000000059] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
271 Sorbo MC, Carioti L, Bellocchi MC, Antonucci F, Sforza D, Lenci I, Ciancio Manuelli M, Armenia D, De Leonardis F, Milana M, Manzia TM, Angelico M, Tisone G, Cento V, Perno CF, Ceccherini-Silberstein F. HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma. Liver Int 2019;39:1986-98. [PMID: 31172639 DOI: 10.1111/liv.14168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
272 Wang Y, Hamang M, Culver A, Jiang H, Yanum J, Garcia V, Lee J, White E, Kusumanchi P, Chalasani N, Liangpunsakul S, Yaden BC, Dai G. Activin B promotes the initiation and progression of liver fibrosis. Hepatol Commun 2022. [PMID: 35866567 DOI: 10.1002/hep4.2037] [Reference Citation Analysis]
273 Parola M. Age-dependent changes in extracellular matrix turnover: An under evaluated issue in the approach to chronic liver diseases. J Hepatol 2016;64:13-5. [PMID: 26432685 DOI: 10.1016/j.jhep.2015.09.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
274 Zhou JJ, Zhu X. Antifibrotic effect of ursolic acid in the liver and related mechanisms. Shijie Huaren Xiaohua Zazhi 2015; 23(21): 3390-3395 [DOI: 10.11569/wcjd.v23.i21.3390] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
275 Barron L, Wynn TA. Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. Am J Physiol Gastrointest Liver Physiol 2011;300:G723-8. [PMID: 21292997 DOI: 10.1152/ajpgi.00414.2010] [Cited by in Crossref: 171] [Cited by in F6Publishing: 158] [Article Influence: 15.5] [Reference Citation Analysis]
276 Wang Y, Du J, Niu X, Fu N, Wang R, Zhang Y, Zhao S, Sun D, Nan Y. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2. Cell Death Dis. 2017;8:e2792. [PMID: 28518142 DOI: 10.1038/cddis.2017.10] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
277 Vinken M. The adverse outcome pathway concept: A pragmatic tool in toxicology. Toxicology 2013;312:158-65. [DOI: 10.1016/j.tox.2013.08.011] [Cited by in Crossref: 251] [Cited by in F6Publishing: 217] [Article Influence: 27.9] [Reference Citation Analysis]
278 Zhao J, Peng L, Cui R, Guo X, Yan M. Dimethyl α-ketoglutarate reduces CCl4-induced liver fibrosis through inhibition of autophagy in hepatic stellate cells. Biochem Biophys Res Commun 2016;481:90-6. [PMID: 27823933 DOI: 10.1016/j.bbrc.2016.11.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
279 Hoshida Y, Fuchs BC, Tanabe KK. Genomic risk of hepatitis C-related hepatocellular carcinoma. J Hepatol 2012;56:729-30. [PMID: 21963516 DOI: 10.1016/j.jhep.2011.08.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
280 Tu X, Zhang Y, Zheng X, Deng J, Li H, Kang Z, Cao Z, Huang Z, Ding Z, Dong L, Chen J, Zang Y, Zhang J. TGF-β-induced hepatocyte lincRNA-p21 contributes to liver fibrosis in mice. Sci Rep 2017;7:2957. [PMID: 28592847 DOI: 10.1038/s41598-017-03175-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
281 Li X, Su Y, Hua X, Xie C, Liu J, Huang Y, Zhou L, Zhang M, Li X, Gao Z. Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis. J Transl Med. 2017;15:75. [PMID: 28399886 DOI: 10.1186/s12967-017-1167-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
282 Li TY, Yang Y, Zhou G, Tu ZK. Immune suppression in chronic hepatitis B infection associated liver disease: A review. World J Gastroenterol 2019; 25(27): 3527-3537 [PMID: 31367154 DOI: 10.3748/wjg.v25.i27.3527] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 32] [Article Influence: 13.7] [Reference Citation Analysis]
283 Murakami Y, Kawada N. MicroRNAs in hepatic pathophysiology. Hepatol Res. 2017;47:60-69. [PMID: 27101519 DOI: 10.1111/hepr.12730] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
284 Routray C, Liu C, Yaqoob U, Billadeau DD, Bloch KD, Kaibuchi K, Shah VH, Kang N. Protein kinase G signaling disrupts Rac1-dependent focal adhesion assembly in liver specific pericytes. Am J Physiol Cell Physiol 2011;301:C66-74. [PMID: 21451103 DOI: 10.1152/ajpcell.00038.2011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
285 D'Ambrosio R, Aghemo A, Rumi MG, Ronchi G, Donato MF, Paradis V, Colombo M, Bedossa P. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis. Hepatology 2012;56:532-43. [PMID: 22271347 DOI: 10.1002/hep.25606] [Cited by in Crossref: 283] [Cited by in F6Publishing: 256] [Article Influence: 28.3] [Reference Citation Analysis]
286 Huang YH, Tiao MM, Huang LT, Chuang JH, Kuo KC, Yang YL, Wang FS. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4. PLoS One. 2015;10:e0136453. [PMID: 26305546 DOI: 10.1371/journal.pone.0136453] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
287 Hur W, Kang BY, Kim SM, Lee GW, Kim JH, Nam MK, Rhim H, Yoon SK. Serine Protease HtrA2/Omi Deficiency Impairs Mitochondrial Homeostasis and Promotes Hepatic Fibrogenesis via Activation of Hepatic Stellate Cells. Cells 2019;8:E1119. [PMID: 31547195 DOI: 10.3390/cells8101119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
288 Goossens N, Nakagawa S, Hoshida Y. Molecular prognostic prediction in liver cirrhosis. World J Gastroenterol 2015; 21(36): 10262-10273 [PMID: 26420954 DOI: 10.3748/wjg.v21.i36.10262] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
289 Wang Q, Du H, Li M, Li Y, Liu S, Gao P, Zhang X, Cheng J. MAPK Signal Transduction Pathway Regulation: A Novel Mechanism of Rat HSC-T6 Cell Apoptosis Induced by FUZHENGHUAYU Tablet. Evid Based Complement Alternat Med 2013;2013:368103. [PMID: 23762126 DOI: 10.1155/2013/368103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
290 Sombetzki M, Fuchs CD, Fickert P, Österreicher CH, Mueller M, Claudel T, Loebermann M, Engelmann R, Langner C, Sahin E. 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis. J Hepatol. 2015;62:871-878. [PMID: 25463533 DOI: 10.1016/j.jhep.2014.11.020] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
291 Huang Y, Liu W, Xiao H, Maitikabili A, Lin Q, Wu T, Huang Z, Liu F, Luo Q, Ouyang G. Matricellular protein periostin contributes to hepatic inflammation and fibrosis. Am J Pathol 2015;185:786-97. [PMID: 25541330 DOI: 10.1016/j.ajpath.2014.11.002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
292 Shi B, Shi J, Qin H. Effect of medicated serum of Curcumae Radix extract on mRNA expression of TIMP-1, MMPs-13 and aI-collagen of HSC-T6 cell. Saudi Pharm J 2017;25:509-12. [PMID: 28579884 DOI: 10.1016/j.jsps.2017.04.015] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
293 Hong F, Saiman Y, Si C, Mosoian A, Bansal MB. X4 Human immunodeficiency virus type 1 gp120 promotes human hepatic stellate cell activation and collagen I expression through interactions with CXCR4. PLoS One 2012;7:e33659. [PMID: 22479424 DOI: 10.1371/journal.pone.0033659] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
294 Yao QY, Xu BL, Wang JY, Liu HC, Zhang SC, Tu CT. Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats. BMC Complement Altern Med 2012;12:156. [PMID: 22978413 DOI: 10.1186/1472-6882-12-156] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 6.8] [Reference Citation Analysis]
295 Li H, Hua J, Guo CX, Wang WX, Wang BJ, Yang DL, Wei P, Lu YP. Pentoxifylline inhibits liver fibrosis via hedgehog signaling pathway. J Huazhong Univ Sci Technolog Med Sci 2016;36:372-6. [PMID: 27376806 DOI: 10.1007/s11596-016-1594-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
296 Huang CF, Sun CC, Zhao F, Zhang YD, Li DJ. miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis. J Gastroenterol. 2015;50:480-490. [PMID: 25155445 DOI: 10.1007/s00535-014-0986-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
297 Khanjarsim V, Karimi J, Khodadadi I, Mohammadalipour A, Goodarzi MT, Solgi G, Hashemnia M. Ameliorative Effects of Nilotinib on CCl4 Induced Liver Fibrosis Via Attenuation of RAGE/HMGB1 Gene Expression and Oxidative Stress in Rat. Chonnam Med J 2017;53:118-26. [PMID: 28584790 DOI: 10.4068/cmj.2017.53.2.118] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
298 Dongaonkar RM, Quick CM, Laine GA, Uray K, Cox CS Jr, Stewart RH. Adaptation of the hepatic transudation barrier to sinusoidal hypertension. Am J Physiol Regul Integr Comp Physiol 2020;318:R722-9. [PMID: 32023079 DOI: 10.1152/ajpregu.00178.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
299 Markowitz GJ, Michelotti GA, Diehl AM, Wang XF. Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma. Sci Bull (Beijing) 2015;60:762-72. [PMID: 26029472 DOI: 10.1007/s11434-015-0772-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
300 Wang A, Zhou F, Li D, Lu JJ, Wang Y, Lin L. γ-Mangostin alleviates liver fibrosis through Sirtuin 3-superoxide-high mobility group box 1 signaling axis. Toxicol Appl Pharmacol 2019;363:142-53. [PMID: 30502394 DOI: 10.1016/j.taap.2018.11.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
301 Zhou YN, Mu YP, Fu WW, Ning BB, Du GL, Chen JM, Sun MY, Zhang H, Hu YY, Liu CH, Xu LM, Liu P. Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice. BMC Complement Altern Med 2015;15:342. [PMID: 26427787 DOI: 10.1186/s12906-015-0862-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
302 Xu XY, Wang WS, Zhang QM, Li JL, Sun JB, Qin TT, Liu HB. Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis. World J Clin Cases 2019; 7(15): 2022-2037 [PMID: 31423434 DOI: 10.12998/wjcc.v7.i15.2022] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
303 Kuo CY, Chiu V, Hsieh PC, Huang CY, Huang SJ, Tzeng IS, Tsai FM, Chen ML, Liu CT, Chen YR. Chrysophanol attenuates hepatitis B virus X protein-induced hepatic stellate cell fibrosis by regulating endoplasmic reticulum stress and ferroptosis. J Pharmacol Sci 2020;144:172-82. [PMID: 32811746 DOI: 10.1016/j.jphs.2020.07.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
304 Qian K, Lei X, Liu G, Fang Y, Xie C, Wu X, Liu Q, Liu G, Cao Z, Zhang J, Kuang T, Yan L, Fu J, Du H, Liu Z, Chu Y, Xu G, Yamamoto H, Mori M, Liang XM, Xu X, Sun Y. Transient Receptor Potential Vanilloid-1 (TRPV1) Alleviates Hepatic Fibrosis via TGF-β Signaling. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/3100943] [Reference Citation Analysis]
305 Kawada N. Evolution of hepatic fibrosis research. Hepatol Res. 2011;41:199-208. [PMID: 21338451 DOI: 10.1111/j.1872-034x.2011.00776.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
306 Yang J, Tao Q, Zhou Y, Chen Q, Li L, Hu S, Liu Y, Zhang Y, Shu J, Zhang X, Zhang L, Zhang L. MicroRNA-708 represses hepatic stellate cells activation and proliferation by targeting ZEB1 through Wnt/β-catenin pathway. Eur J Pharmacol 2020;871:172927. [PMID: 31962101 DOI: 10.1016/j.ejphar.2020.172927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
307 Schuppan D, Kim YO. Evolving therapies for liver fibrosis. J Clin Invest. 2013;123:1887-1901. [PMID: 23635787 DOI: 10.1172/jci66028] [Cited by in Crossref: 393] [Cited by in F6Publishing: 226] [Article Influence: 43.7] [Reference Citation Analysis]
308 Otranto M, Sarrazy V, Bonté F, Hinz B, Gabbiani G, Desmoulière A. The role of the myofibroblast in tumor stroma remodeling. Cell Adh Migr. 2012;6:203-219. [PMID: 22568985 DOI: 10.4161/cam.20377] [Cited by in Crossref: 142] [Cited by in F6Publishing: 131] [Article Influence: 14.2] [Reference Citation Analysis]
309 Li A, Wang J, Wu M, Zhang X, Zhang H. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: Persistent p27Kip1 induction by interfering with PI3K/Akt/FOXO3a signaling pathway. European Journal of Pharmacology 2015;747:71-87. [DOI: 10.1016/j.ejphar.2014.11.040] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
310 Song BJ, Rockey DC. Status of research on vitamin D supplementation in treating or preventing liver fibrosis. Liver Int 2013;33:653-5. [PMID: 23560728 DOI: 10.1111/liv.12147] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
311 Hauff P, Gottwald U, Ocker M. Early to Phase II drugs currently under investigation for the treatment of liver fibrosis. Expert Opin Investig Drugs. 2015;24:309-327. [PMID: 25547844 DOI: 10.1517/13543784.2015.997874] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
312 Fan W, Liu T, Chen W, Hammad S, Longerich T, Hausser I, Fu Y, Li N, He Y, Liu C, Zhang Y, Lian Q, Zhao X, Yan C, Li L, Yi C, Ling Z, Ma L, Zhao X, Xu H, Wang P, Cong M, You H, Liu Z, Wang Y, Chen J, Li D, Hui L, Dooley S, Hou J, Jia J, Sun B. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice. Gastroenterology 2019;157:1352-1367.e13. [PMID: 31362006 DOI: 10.1053/j.gastro.2019.07.036] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
313 Zhang C, Liu H, Cui Y, Li X, Zhang Z, Zhang Y, Wang D. Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model. Int J Nanomedicine 2016;11:1097-108. [PMID: 27051285 DOI: 10.2147/IJN.S101366] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
314 Gijbels E, Vinken M. An Update on Adverse Outcome Pathways Leading to Liver Injury. Appl In Vitro Toxicol 2017;3:283-5. [PMID: 30918914 DOI: 10.1089/aivt.2017.0027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
315 Li Y, Lua I, French SW, Asahina K. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2016;310:G262-72. [PMID: 26702136 DOI: 10.1152/ajpgi.00257.2015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
316 Chung YH, Huang YH, Chu TH, Chen CL, Lin PR, Huang SC, Wu DC, Huang CC, Hu TH, Kao YH, Tai MH. BMP-2 restoration aids in recovery from liver fibrosis by attenuating TGF-β1 signaling. Lab Invest 2018;98:999-1013. [PMID: 29789683 DOI: 10.1038/s41374-018-0069-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
317 Xu S, Kang CH, Gou X, Peng Q, Yan J, Zhuo S, Cheng CL, He Y, Kang Y, Xia W, So PT, Welsch R, Rajapakse JC, Yu H. Quantification of liver fibrosis via second harmonic imaging of the Glisson's capsule from liver surface. J Biophotonics 2016;9:351-63. [PMID: 26131709 DOI: 10.1002/jbio.201500001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
318 Kaffe E, Katsifa A, Xylourgidis N, Ninou I, Zannikou M, Harokopos V, Foka P, Dimitriadis A, Evangelou K, Moulas AN, Georgopoulou U, Gorgoulis VG, Dalekos GN, Aidinis V. Hepatocyte autotaxin expression promotes liver fibrosis and cancer. Hepatology 2017;65:1369-83. [PMID: 27981605 DOI: 10.1002/hep.28973] [Cited by in Crossref: 93] [Cited by in F6Publishing: 81] [Article Influence: 18.6] [Reference Citation Analysis]
319 Tacke F, Weiskirchen R. Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques. Expert Rev Gastroenterol Hepatol. 2012;6:67-80. [PMID: 22149583 DOI: 10.1586/egh.11.92] [Cited by in Crossref: 121] [Cited by in F6Publishing: 118] [Article Influence: 12.1] [Reference Citation Analysis]
320 Zhang S, Gong Y, Xiao J, Chai Y, Lei J, Huang H, Xiang T, Shen W. A COL1A1 Promoter-Controlled Expression of TGF-β Soluble Receptor Inhibits Hepatic Fibrosis Without Triggering Autoimmune Responses. Dig Dis Sci 2018;63:2662-72. [PMID: 29934723 DOI: 10.1007/s10620-018-5168-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
321 Zhao X, Fu J, Xu A, Yu L, Zhu J, Dai R, Su B, Luo T, Li N, Qin W, Wang B, Jiang J, Li S, Chen Y, Wang H. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway. Cell Death Dis 2015;6:e1751. [PMID: 25950481 DOI: 10.1038/cddis.2015.120] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
322 Ahmad A, Afroz N, Gupta UD, Ahmad R. Vitamin B 12 supplement alleviates N ′-nitrosodimethylamine-induced hepatic fibrosis in rats. Pharmaceutical Biology 2013;52:516-23. [DOI: 10.3109/13880209.2013.864682] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
323 Cai S, Deng Y, Peng H, Shen J. Role of Tetraspanins in Hepatocellular Carcinoma. Front Oncol 2021;11:723341. [PMID: 34540692 DOI: 10.3389/fonc.2021.723341] [Reference Citation Analysis]
324 Hayes CN, Zhang P, Zhang Y, Chayama K. Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection. Viruses. 2018;10. [PMID: 30274202 DOI: 10.3390/v10100531] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
325 Yang D, Li L, Qian S, Liu L. Evodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway. J Nat Med 2018;72:145-54. [PMID: 28936800 DOI: 10.1007/s11418-017-1122-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
326 Kalifu B, Maitiseyiti A, Ge X, Chen X, Meng Y. Expression profile of circular RNAs in cystic echinococcosis pericystic tissue. J Clin Lab Anal 2021;35:e23687. [PMID: 33411343 DOI: 10.1002/jcla.23687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
327 Iredale JP, Pellicoro A. "It is a good morning exercise for a research scientist to discard a pet hypothesis every day before breakfast: it keeps him young" (Konrad Lorenz, 1903-1989). Gastroenterology 2011;140:1395-8. [PMID: 21443887 DOI: 10.1053/j.gastro.2011.03.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
328 Liu CH, Chan KM, Chiang T, Liu JY, Chern GG, Hsu FF, Wu YH, Liu YC, Chen Y. Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis. Mol Pharm 2016;13:2253-62. [PMID: 27224003 DOI: 10.1021/acs.molpharmaceut.5b00913] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
329 Jeftic I, Jovicic N, Pantic J, Arsenijevic N, Lukic ML, Pejnovic N. Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis. Mol Med 2015;21:453-65. [PMID: 26018806 DOI: 10.2119/molmed.2014.00178] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
330 Matsuzaki K, Seki T, Okazaki K. TGF-β signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases. J Gastroenterol 2014;49:971-81. [PMID: 24263677 DOI: 10.1007/s00535-013-0910-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
331 Yu Y, Sun X, Gu J, Yu C, Wen Y, Gao Y, Xia Q, Kong X. Deficiency of DJ-1 Ameliorates Liver Fibrosis through Inhibition of Hepatic ROS Production and Inflammation. Int J Biol Sci 2016;12:1225-35. [PMID: 27766037 DOI: 10.7150/ijbs.15154] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
332 Okada H, Honda M, Campbell JS, Takegoshi K, Sakai Y, Yamashita T, Shirasaki T, Takabatake R, Nakamura M, Tanaka T, Kaneko S. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice. Cancer Sci 2015;106:1143-52. [PMID: 26122702 DOI: 10.1111/cas.12730] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
333 Crespo Yanguas S, Willebrords J, Maes M, da Silva TC, Veloso Alves Pereira I, Cogliati B, Zaidan Dagli ML, Vinken M. Connexins and pannexins in liver damage. EXCLI J 2016;15:177-86. [PMID: 27065778 DOI: 10.17179/excli2016-119] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
334 Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmoulière A, Varga J, De Wever O, Mareel M, Gabbiani G. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol. 2012;180:1340-1355. [PMID: 22387320 DOI: 10.1016/j.ajpath.2012.02.004] [Cited by in Crossref: 789] [Cited by in F6Publishing: 765] [Article Influence: 78.9] [Reference Citation Analysis]
335 Oh SH, Swiderska-Syn M, Jewell ML, Premont RT, Diehl AM. Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytes. J Hepatol 2018;69:359-67. [PMID: 29758331 DOI: 10.1016/j.jhep.2018.05.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
336 Mohamadnejad M, Sohrabpour AA, Malekzadeh R. Letter: The reversal of liver cirrhosis--what we know and what we need to know--authors' reply. Aliment Pharmacol Ther 2013;37:371-2. [PMID: 23281731 DOI: 10.1111/apt.12184] [Reference Citation Analysis]
337 Zhao L, Gandhi CR, Gao ZH. Involvement of cytosolic phospholipase A2 alpha signalling pathway in spontaneous and transforming growth factor-beta-induced activation of rat hepatic stellate cells. Liver Int. 2011;31:1565-1573. [PMID: 22093332 DOI: 10.1111/j.1478-3231.2011.02632.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
338 Zheng QF, Bai L, Duan ZP, Han YP, Zheng SJ, Chen Y, Li JS. M2-like Kupffer cells in fibrotic liver may protect against acute insult. World J Gastroenterol 2017; 23(20): 3655-3663 [PMID: 28611518 DOI: 10.3748/wjg.v23.i20.3655] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
339 Eulenberg VM, Lidbury JA. Hepatic Fibrosis in Dogs. J Vet Intern Med. 2018;32:26-41. [PMID: 29194760 DOI: 10.1111/jvim.14891] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
340 Lu C, Xu W, Zhang F, Shao J, Zheng S. Nrf2 knockdown attenuates the ameliorative effects of ligustrazine on hepatic fibrosis by targeting hepatic stellate cell transdifferentiation. Toxicology 2016;365:35-47. [DOI: 10.1016/j.tox.2016.07.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
341 Muthiah MD, Huang DQ, Zhou L, Jumat NH, Choolani M, Chan JKY, Wee A, Lim SG, Dan YY. A murine model demonstrating reversal of structural and functional correlates of cirrhosis with progenitor cell transplantation. Sci Rep 2019;9:15446. [PMID: 31659188 DOI: 10.1038/s41598-019-51189-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
342 Wu JS, Chiu V, Lan CC, Wang MC, Tzeng IS, Kuo CY, Hsieh PC. Chrysophanol Prevents Lipopolysaccharide-Induced Hepatic Stellate Cell Activation by Upregulating Apoptosis, Oxidative Stress, and the Unfolded Protein Response. Evid Based Complement Alternat Med 2020;2020:8426051. [PMID: 32714424 DOI: 10.1155/2020/8426051] [Reference Citation Analysis]
343 Dong S, Chen QL, Su SB. Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis. Evid Based Complement Alternat Med 2015;2015:125659. [PMID: 26221168 DOI: 10.1155/2015/125659] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
344 Jonscher KR, Alfonso-Garcia A, Suhalim JL, Orlicky DJ, Potma EO, Ferguson VL, Bouxsein ML, Bateman TA, Stodieck LS, Levi M, Friedman JE, Gridley DS, Pecaut MJ. Spaceflight Activates Lipotoxic Pathways in Mouse Liver. PLoS One 2016;11:e0152877. [PMID: 27097220 DOI: 10.1371/journal.pone.0152877] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
345 Mohammadalipour A, Hashemnia M, Goudarzi F, Ravan AP. Increasing the effectiveness of tyrosine kinase inhibitor (TKI) in combination with a statin in reducing liver fibrosis. Clin Exp Pharmacol Physiol 2019;46:1183-93. [PMID: 31396972 DOI: 10.1111/1440-1681.13157] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
346 Park JS, Oh Y, Park YJ, Park O, Yang H, Slania S, Hummers LK, Shah AA, An HT, Jang J, Horton MR, Shin J, Dietz HC, Song E, Na DH, Park EJ, Kim K, Lee KC, Roschke VV, Hanes J, Pomper MG, Lee S. Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma. Nat Commun 2019;10:1128. [PMID: 30850660 DOI: 10.1038/s41467-019-09101-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
347 Gu L, Deng WS, Sun XF, Zhou H, Xu Q. Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance. Mol Med Rep 2016;14:1153-61. [PMID: 27315465 DOI: 10.3892/mmr.2016.5392] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
348 Miao Y, Wu Y, Jin Y, Lei M, Nan J, Wu X. Benzoquinone derivatives with antioxidant activity inhibit activated hepatic stellate cells and attenuate liver fibrosis in TAA-induced mice. Chemico-Biological Interactions 2020;317:108945. [DOI: 10.1016/j.cbi.2020.108945] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
349 Yan G, Li B, Xin X, Xu M, Ji G, Yu H. MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1. Med Sci Monit. 2015;21:3008-3015. [PMID: 26437572 DOI: 10.12659/msm.894000] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
350 Zhang F, Lu Y, Zheng S. Peroxisome proliferator-activated receptor-γ cross-regulation of signaling events implicated in liver fibrogenesis. Cell Signal. 2012;24:596-605. [PMID: 22108088 DOI: 10.1016/j.cellsig.2011.11.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
351 Giebeler A, Streetz KL, Soehnlein O, Neumann U, Wang JM, Brandenburg LO. Deficiency of formyl peptide receptor 1 and 2 is associated with increased inflammation and enhanced liver injury after LPS-stimulation. PLoS One 2014;9:e100522. [PMID: 24956481 DOI: 10.1371/journal.pone.0100522] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
352 Elsharkawy A, Samir R, El-Kassas M. Fibrosis regression following hepatitis C antiviral therapy. World J Hepatol 2022; 14(6): 1120-1130 [DOI: 10.4254/wjh.v14.i6.1120] [Reference Citation Analysis]
353 Kourouklis AP, Kaylan KB, Underhill GH. Substrate stiffness and matrix composition coordinately control the differentiation of liver progenitor cells. Biomaterials 2016;99:82-94. [DOI: 10.1016/j.biomaterials.2016.05.016] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
354 Strathearn LS, Stepanov AI, Font-Burgada J. Inflammation in Primary and Metastatic Liver Tumorigenesis-Under the Influence of Alcohol and High-Fat Diets. Nutrients 2020;12:E933. [PMID: 32230953 DOI: 10.3390/nu12040933] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
355 Balachandran YL, Wang W, Yang H, Tong H, Wang L, Liu F, Chen H, Zhong K, Liu Y, Jiang X. Heterogeneous Iron Oxide/Dysprosium Oxide Nanoparticles Target Liver for Precise Magnetic Resonance Imaging of Liver Fibrosis. ACS Nano 2022;16:5647-59. [PMID: 35312295 DOI: 10.1021/acsnano.1c10618] [Reference Citation Analysis]
356 Song M, Zhang H, Chen Z, Yang J, Li J, Shao S, Liu J. Shikonin reduces hepatic fibrosis by inducing apoptosis and inhibiting autophagy via the platelet-activating factor-mitogen-activated protein kinase axis. Exp Ther Med 2021;21:28. [PMID: 33262814 DOI: 10.3892/etm.2020.9460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
357 Huang S, Chen L, Lu L, Li L. The apelin-APJ axis: A novel potential therapeutic target for organ fibrosis. Clin Chim Acta. 2016;456:81-88. [PMID: 26944568 DOI: 10.1016/j.cca.2016.02.025] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
358 Onozuka I, Kakinuma S, Kamiya A, Miyoshi M, Sakamoto N, Kiyohashi K, Watanabe T, Funaoka Y, Ueyama M, Nakagawa M, Koshikawa N, Seiki M, Nakauchi H, Watanabe M. Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice. Biochem Biophys Res Commun 2011;406:134-40. [PMID: 21300023 DOI: 10.1016/j.bbrc.2011.02.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
359 Langiewicz M, Graf R, Humar B, Clavien PA. JNK1 induces hedgehog signaling from stellate cells to accelerate liver regeneration in mice. J Hepatol. 2018;69:666-675. [PMID: 29709677 DOI: 10.1016/j.jhep.2018.04.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
360 Friedman SL. Hepatic Fibrosis. In: Schiff ER, Maddrey WC, Sorrell MF, editors. Schiff's Diseases of the Liver. Oxford: Wiley-Blackwell; 2011. pp. 295-315. [DOI: 10.1002/9781119950509.ch12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
361 Yang L, Han B, Zhang M, Wang YH, Tao K, Zhu MX, He K, Zhang ZG, Hou S. Activation of BK Channels Prevents Hepatic Stellate Cell Activation and Liver Fibrosis Through the Suppression of TGFβ1/SMAD3 and JAK/STAT3 Profibrotic Signaling Pathways. Front Pharmacol 2020;11:165. [PMID: 32210801 DOI: 10.3389/fphar.2020.00165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
362 Farrar CT, Gale EM, Kennan R, Ramsay I, Masia R, Arora G, Looby K, Wei L, Kalpathy-Cramer J, Bunzel MM, Zhang C, Zhu Y, Akiyama TE, Klimas M, Pinto S, Diyabalanage H, Tanabe KK, Humblet V, Fuchs BC, Caravan P. CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver Fibrosis. Radiology 2018;287:581-9. [PMID: 29156148 DOI: 10.1148/radiol.2017170595] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
363 Lao Y, Li Y, Zhang P, Shao Q, Lin W, Qiu B, Lv Y, Tang L, Su S, Zhang H, Tian C, Sun A, Wei H, Zhang P, Wu Y, Jiang Y, He F. Targeting Endothelial Erk1/2-Akt Axis as a Regeneration Strategy to Bypass Fibrosis during Chronic Liver Injury in Mice. Mol Ther 2018;26:2779-97. [PMID: 30266653 DOI: 10.1016/j.ymthe.2018.08.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
364 Lin YC, Wang FS, Yang YL, Chuang YT, Huang YH. MicroRNA-29a mitigation of toll-like receptor 2 and 4 signaling and alleviation of obstructive jaundice-induced fibrosis in mice. Biochem Biophys Res Commun 2018;496:880-6. [PMID: 29366780 DOI: 10.1016/j.bbrc.2018.01.132] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
365 Shi H, Dong L, Jiang J, Zhao J, Zhao G, Dang X, Lu X, Jia M. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology. 2013;303:107-114. [PMID: 23146752 DOI: 10.1016/j.tox.2012.10.025] [Cited by in Crossref: 135] [Cited by in F6Publishing: 123] [Article Influence: 13.5] [Reference Citation Analysis]
366 Gwon MG, Kim JY, An HJ, Kim WH, Gu H, Kim MK, Park SC, Park KK. Antifibrotic Effect of Smad Decoy Oligodeoxynucleotide in a CCl₄-Induced Hepatic Fibrosis Animal Model. Molecules 2018;23:E1991. [PMID: 30103395 DOI: 10.3390/molecules23081991] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
367 Mejias M, Gallego J, Naranjo-Suarez S, Ramirez M, Pell N, Manzano A, Suñer C, Bartrons R, Mendez R, Fernandez M. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis. Gastroenterology 2020;159:273-88. [PMID: 32169429 DOI: 10.1053/j.gastro.2020.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
368 Zhou XY, Yu ZJ, Yan D, Wang HM, Huang YH, Sha J, Xu FY, Cai ZY, Min WP. BML-11, a lipoxin receptor agonist, protected carbon tetrachloride-induced hepatic fibrosis in rats. Inflammation 2013;36:1101-6. [PMID: 23640201 DOI: 10.1007/s10753-013-9643-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
369 Challa AA, Stefanovic B. A novel role of vimentin filaments: binding and stabilization of collagen mRNAs. Mol Cell Biol 2011;31:3773-89. [PMID: 21746880 DOI: 10.1128/MCB.05263-11] [Cited by in Crossref: 94] [Cited by in F6Publishing: 51] [Article Influence: 8.5] [Reference Citation Analysis]
370 Li JF, Zheng SJ, Duan ZP. Liver fibrosis: Role of oxidative stress and therapeutic countermeasures. Shijie Huaren Xiaohua Zazhi 2013; 21(17): 1573-1578 [DOI: 10.11569/wcjd.v21.i17.1573] [Reference Citation Analysis]
371 Periasamy S, Hsu DZ, Chang PC, Liu MY. Sesame oil attenuates nutritional fibrosing steatohepatitis by modulating matrix metalloproteinases-2, 9 and PPAR-γ. J Nutr Biochem 2014;25:337-44. [PMID: 24445078 DOI: 10.1016/j.jnutbio.2013.11.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
372 Bellocchi MC, Aragri M, Carioti L, Fabeni L, Pipitone RM, Brancaccio G, Sorbo MC, Barbaliscia S, Di Maio VC, Bronte F, Grimaudo S, Mazzucco W, Frigeri F, Cantone M, Pinto A, Perno CF, Craxì A, Gaeta GB, Di Marco V, Ceccherini-Silberstein F. NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients. Cells 2019;8:E666. [PMID: 31269695 DOI: 10.3390/cells8070666] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
373 Friedman SL. Protect thee from the sins of thy fathers? Nat Med. 2012;18:1331-1332. [PMID: 22961157 DOI: 10.1038/nm.2936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
374 Liu Y, Liu J, Fite BZ, Foiret J, Ilovitsh A, Leach JK, Dumont E, Caskey CF, Ferrara KW. Supersonic transient magnetic resonance elastography for quantitative assessment of tissue elasticity. Phys Med Biol 2017;62:4083-106. [PMID: 28426437 DOI: 10.1088/1361-6560/aa6674] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
375 Chou MH, Huang YH, Lin TM, Du YY, Tsai PC, Hsieh CS, Chuang JH. Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype. Biochem J 2012;447:25-34. [PMID: 22765640 DOI: 10.1042/BJ20112058] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
376 Hessin A, Hegazy R, Hassan A, Yassin N, Kenawy S. Lactoferrin Enhanced Apoptosis and Protected Against Thioacetamide-Induced Liver Fibrosis in Rats. Open Access Maced J Med Sci 2015;3:195-201. [PMID: 27275221 DOI: 10.3889/oamjms.2015.038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
377 Lin HY, Wang FS, Yang YL, Huang YH. MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice. Cells 2019;8:E1298. [PMID: 31652636 DOI: 10.3390/cells8101298] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
378 Zhou D, Wang J, He LN, Li BH, Ding YN, Chen YW, Fan JG. Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-γ. Exp Ther Med 2017;13:780-6. [PMID: 28352366 DOI: 10.3892/etm.2017.4033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
379 Ahmad A, Ahmad R. Proteomic approach to identify molecular signatures during experimental hepatic fibrosis and resveratrol supplementation. International Journal of Biological Macromolecules 2018;119:1218-27. [DOI: 10.1016/j.ijbiomac.2018.08.062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
380 Jiao J, Ooka K, Fey H, Fiel MI, Rahmman AH, Kojima K, Hoshida Y, Chen X, de Paula T, Vetter D, Sastre D, Lee KH, Lee Y, Bansal M, Friedman SL, Merad M, Aloman C. Interleukin-15 receptor α on hepatic stellate cells regulates hepatic fibrogenesis in mice. J Hepatol 2016;65:344-53. [PMID: 27154062 DOI: 10.1016/j.jhep.2016.04.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
381 Pittala S, Krelin Y, Kuperman Y, Shoshan-Barmatz V. A Mitochondrial VDAC1-Based Peptide Greatly Suppresses Steatosis and NASH-Associated Pathologies in a Mouse Model. Mol Ther 2019;27:1848-62. [PMID: 31375359 DOI: 10.1016/j.ymthe.2019.06.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
382 Alisi A, de Vito R, Monti L, Nobili V. Liver fibrosis in paediatric liver diseases. Best Pract Res Clin Gastroenterol. 2011;25:259-268. [PMID: 21497743 DOI: 10.1016/j.bpg.2011.02.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
383 Xie H, Su D, Zhang J, Ji D, Mao J, Hao M, Wang Q, Yu M, Mao C, Lu T. Raw and vinegar processed Curcuma wenyujin regulates hepatic fibrosis via bloking TGF-β/Smad signaling pathways and up-regulation of MMP-2/TIMP-1 ratio. Journal of Ethnopharmacology 2020;246:111768. [DOI: 10.1016/j.jep.2019.01.045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
384 Wang B, Li W, Chen Y, Wang Y, Sun C, Chen Y, Lu H, Fan J, Li D. Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis. Med Sci Monit 2012;18:BR394-401. [PMID: 23018346 DOI: 10.12659/msm.883479] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
385 Kang R, Tian W, Cao W, Sun Y, Zhang HN, Feng YD, Li C, Li ZZ, Li XQ. Ligustroflavone ameliorates CCl4-induced liver fibrosis through down-regulating the TGF-β/Smad signaling pathway. Chin J Nat Med 2021;19:170-80. [PMID: 33781450 DOI: 10.1016/S1875-5364(21)60018-3] [Reference Citation Analysis]
386 Yee RM, Lehil MS, Rongey C, Shen H, Cozen ML, Monto A, Ryan JC. Impaired lymphocyte reactivity measured by immune function testing in untransplanted patients with cirrhosis. Clin Vaccine Immunol. 2013;20:526-529. [PMID: 23389930 DOI: 10.1128/cvi.00595-12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
387 Wang H, Yin S. Natural killer T cells in liver injury, inflammation and cancer. Expert Rev Gastroenterol Hepatol 2015;9:1077-85. [PMID: 26068039 DOI: 10.1586/17474124.2015.1056738] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
388 Vallée A, Lecarpentier Y. TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts. Cell Biosci 2019;9:98. [PMID: 31827764 DOI: 10.1186/s13578-019-0362-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
389 Hinz B. Mechanical aspects of lung fibrosis: a spotlight on the myofibroblast. Proc Am Thorac Soc 2012;9:137-47. [PMID: 22802288 DOI: 10.1513/pats.201202-017AW] [Cited by in Crossref: 100] [Cited by in F6Publishing: 47] [Article Influence: 10.0] [Reference Citation Analysis]
390 Deng YR, Yoshida K, Jin QL, Murata M, Yamaguchi T, Tsuneyama K, Moritoki Y, Niu JQ, Matsuzaki K, Lian ZX. Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection. Clin Exp Immunol 2014;176:102-11. [PMID: 24372395 DOI: 10.1111/cei.12259] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
391 Yu F, Guo Y, Chen B, Dong P, Zheng J. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Lab Invest. 2015;95:781-789. [PMID: 25915722 DOI: 10.1038/labinvest. 2015.58] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
392 He H, An ZM. Wnt signaling pathway and liver fibrosis: Recent research status. Shijie Huaren Xiaohua Zazhi 2014; 22(25): 3766-3772 [DOI: 10.11569/wcjd.v22.i25.3766] [Reference Citation Analysis]
393 Huang X, Wang X, Lv Y, Xu L, Lin J, Diao Y. Protection effect of kallistatin on carbon tetrachloride-induced liver fibrosis in rats via antioxidative stress. PLoS One 2014;9:e88498. [PMID: 24558397 DOI: 10.1371/journal.pone.0088498] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
394 Bai L, Kong M, Zheng Q, Zhang X, Liu X, Zu K, Chen Y, Zheng S, Li J, Ren F, Lou J, Liu S, Duan Z. Inhibition of the translocation and extracellular release of high-mobility group box 1 alleviates liver damage in fibrotic mice in response to D-galactosamine/lipopolysaccharide challenge. Mol Med Rep 2016;13:3835-41. [PMID: 27035642 DOI: 10.3892/mmr.2016.5003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
395 Lu N, Liu Y, Tang A, Chen L, Miao D, Yuan X. Hepatocyte-Specific Ablation of PP2A Catalytic Subunit α Attenuates Liver Fibrosis Progression via TGF-β1/Smad Signaling. Biomed Res Int. 2015;2015:794862. [PMID: 25710025 DOI: 10.1155/2015/794862] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
396 Kuo LM, Chen PJ, Sung PJ, Chang YC, Ho CT, Wu YH, Hwang TL. The Bioactive Extract of Pinnigorgia sp. Induces Apoptosis of Hepatic Stellate Cells via ROS-ERK/JNK-Caspase-3 Signaling. Mar Drugs 2018;16:E19. [PMID: 29315209 DOI: 10.3390/md16010019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
397 Nobili V, Monti L, Alisi A, Zupone CL, Pietrobattista A, Tomà P. Transient elastography for assessment of fibrosis in paediatric liver disease. Pediatr Radiol 2011;41:1232-8. [DOI: 10.1007/s00247-011-2143-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
398 Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014; 20(32): 11033-11053 [PMID: 25170193 DOI: 10.3748/wjg.v20.i32.11033] [Cited by in CrossRef: 135] [Cited by in F6Publishing: 118] [Article Influence: 16.9] [Reference Citation Analysis]
399 Liu YW, Chiu YT, Fu SL, Huang YT. Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation. J Biomed Sci 2015;22:63. [PMID: 26231226 DOI: 10.1186/s12929-015-0168-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
400 Sun Y, Liu B, Xie J, Jiang X, Xiao B, Hu X, Xiang J. Aspirin attenuates liver fibrosis by suppressing TGF‑β1/Smad signaling. Mol Med Rep 2022;25:181. [PMID: 35322863 DOI: 10.3892/mmr.2022.12697] [Reference Citation Analysis]